Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

C3_DIGESTIVE_ORGANS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_OESOPHAGUS_EXALLC C3_STOMACH_EXALLC C3_SMALL_INTESTINE_EXALLC C3_COLON_EXALLC C3_RECTOSIGMOID_JUNCTION_EXALLC C3_RECTUM_EXALLC C3_ANUS_ANALCANAL_EXALLC C3_BILIARY_GALLBLADDER_EXALLC C3_PANCREAS_EXALLC C3_DIGESTIVE_ORGANS_NAS_EXALLC	21578
6. Filter based on genotype QC (FinnGen only)	21578

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_DIGESTIVE_ORGANS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_OESOPHAGUS_EXALLC\|C3_STOMACH_EXALLC\|C3_SMALL_INTESTINE_EXALLC\|C3_COLON_EXALLC\|C3_RECTOSIGMOID_JUNCTION_EXALLC\|C3_RECTUM_EXALLC\|C3_ANUS_ANALCANAL_EXALLC\|C3_BILIARY_GALLBLADDER_EXALLC\|C3_PANCREAS_EXALLC\|C3_DIGESTIVE_ORGANS_NAS_EXALLC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21578	8743	12835
Unadjusted period prevalence (%)	4.57	2.98	5.66
Median age at first event (years)	69.04	67.81	69.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13704: Matched controls
119554

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

34.5

323.0

525

138

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

7.4

323.0

3027

4425

WX302

NOMESCO Finland

Thoracal epidural anesthesy

36.7

323.0

3335

1039

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

19.6

323.0

735

344

TPH07

NOMESCO Finland

Cathetrisation of artery

5.0

323.0

2708

5631

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

18.5

323.0

779

388

UJF32

NOMESCO Finland

Coloscopy

5.1

323.0

6857

19570

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

323.0

1686

4342

WF003

NOMESCO Finland

Adjuvant radiotherapy

212.9

323.0

403

JN4CD

NOMESCO Finland

Very extensive body CT

22.1

323.0

1658

741

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.5

323.0

1827

2758

JAH01

NOMESCO Finland

Laparoscopy

6.6

323.0

962

1345

WF001

NOMESCO Finland

Preoperative radiotherapy

8355.5

323.0

905

A04AA02

ATC

granisetron; systemic, transdermal

1686.7

323.0

3578

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1941.8

323.0

2751

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

323.0

5170

17180

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

2124.6

323.0

488

JFF23

NOMESCO Finland

Transversostomy

74.9

323.0

816

101

WW500

NOMESCO Finland

Blood transfusion

10.3

323.0

1003

911

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

5750.2

323.0

1759

JN3AD

NOMESCO Finland

Abdominal CT examination

4.2

323.0

1726

3923

JN4AD

NOMESCO Finland

Body CT examination

17.1

323.0

2824

1791

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

323.0

924

JFB00

NOMESCO Finland

Partial resection of small intestine

12.9

323.0

668

474

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

10.4

323.0

1278

1165

TJF80

NOMESCO Finland

Ostomy education

49.9

323.0

560

102

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

2189.9

323.0

502

A04AA55

ATC

palonosetron, combinations; systemic

+∞

323.0

662

WF049

NOMESCO Finland

Radiotherapy of metastasis

1726.4

323.0

784

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

671.3

323.0

1692

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

323.0

331

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

323.0

496

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

323.0

373

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4441.0

323.0

500

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

123.3

323.0

874

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

7413

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

1199.5

323.0

779

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

323.0

354

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

3032.9

323.0

680

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

1714

ZX090

NOMESCO Finland

Other technic of radiotherapy

320.2

323.0

499

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

445.4

323.0

1087

WF004

NOMESCO Finland

Palliative radiotherapy

943.6

323.0

420

WX600

NOMESCO Finland

Single shot through catheter

30.6

323.0

624

186

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

16384.0

323.0

1959

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

323.0

3692

14185

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

203.2

323.0

934

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

17.0

323.0

891

486

115

Kela drug reimbursment

Breast cancer

+∞

323.0

455

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

26.8

323.0

1964

741

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

309.6

323.0

648

ZX070

NOMESCO Finland

Intensity modified radiotherapy

661.0

323.0

441

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

323.0

1483

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

323.0

368

Z93.3

ICD-10 Finland

Colostomy status

53.6

323.0

544

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

323.0

2096

5891

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

664

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

818.5

323.0

1201

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

323.0

517

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

1708.1

323.0

398

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

543.6

323.0

365

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

18.8

323.0

577

279

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

7170.1

323.0

785

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

596

PJA12

NOMESCO Finland

Sentinel node biopsy

389.8

323.0

435

B01AB05

ATC

enoxaparin; parenteral

4.3

323.0

6750

22089

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

323.0

345

H02AB02

ATC

dexamethasone; systemic

104.3

323.0

4064

481

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

50.4

323.0

496

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

323.0

1241

A09AA02

ATC

multienzymes (lipase, protease etc.)

12.6

323.0

884

649

ZX120

NOMESCO Finland

Intravenous

4.7

323.0

1915

3962

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

3281.5

323.0

1071

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

8.2

323.0

889

1000

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

59.8

323.0

691

106

Z51.5

ICD-10 Finland

Palliative care

28.2

323.0

2595

982

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

323.0

646

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

11.8

323.0

2627

2350

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.2

323.0

5907

18371

JG1BG

NOMESCO Finland

MRI of rectum

206.5

323.0

611

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

796.9

323.0

612

D75

ICPC

Malignant neoplasm colon/rectum

395.9

323.0

652

JG1CG

NOMESCO Finland

Extensive MRI of rectum

156.5

323.0

485

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

323.0

379

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

581

K83.1

ICD-10 Finland

Obstruction of bile duct

18.0

323.0

590

298

A03FA01

ATC

metoclopramide; systemic, rectal

17.1

323.0

7089

7064

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

55.0

323.0

673

112

JN4BD

NOMESCO Finland

Extensive body CT

21.7

323.0

4623

2736

JLC30

NOMESCO Finland

Pancreatoduodenectomy

100.2

323.0

434

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

99.4

323.0

1072

102

XX3DW

NOMESCO Finland

Time consuming IT work

7.7

323.0

1970

2544

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

30.3

323.0

503

150

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.8

323.0

1169

749

C61

ICD-10 Finland

Malignant neoplasm of prostate

226.3

323.0

852

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

323.0

1083

N02AA05

ATC

oxycodone; systemic

6.5

323.0

4126

7412

L03AA02

ATC

filgrastim; parenteral

145.1

323.0

620

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

7760.1

323.0

845

116

Kela drug reimbursment

Prostate cancer

+∞

323.0

431

JFB30

NOMESCO Finland

Right hemicolectomy

62.3

323.0

1136

173

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

323.0

554

JAH00

NOMESCO Finland

Laparotomy

9.5

323.0

925

904

WZC30

NOMESCO Finland

Teaching

6.4

323.0

3422

5898

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

323.0

638

A79

ICPC

Malignancy NOS

169.0

323.0

377

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

323.0

337

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

323.0

521

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

443

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

1557.2

323.0

498

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3070.1

323.0

352

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

2884.4

323.0

649

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

323.0

468

A04AA01

ATC

ondansetron; systemic, rectal

20.8

323.0

1836

882

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

365

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2573

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

323.0

610

B01AB10

ATC

tinzaparin; parenteral

7.7

323.0

1831

2340

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

8.3

323.0

1102

1251

WF002

NOMESCO Finland

Radical radiotherapy

105.5

323.0

830

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

323.0

5229

23209

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

2893

WX402

NOMESCO Finland

General anaesthesia

3.6

323.0

2854

8179

A04AD12

ATC

aprepitant; systemic

1278.1

323.0

557

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3839.6

323.0

1600

L03AA13

ATC

pegfilgrastim; parenteral

761.4

323.0

586

R4190

NOMESCO Finland

Nutritional therapy

10.9

323.0

947

811

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.7

323.0

2672

5868

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

17.3

323.0

1249

687

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

323.0

815

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

3015.1

323.0

346

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

323.0

524

L01BC06

ATC

capecitabine; oral

+∞

323.0

4440

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

6.2

319.4

934

1385

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2814.2

319.0

324

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

75.0

314.5

376

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

945.4

308.9

318

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

76.5

307.8

367

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

6.5

304.9

865

1230

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

24.8

304.5

454

165

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2650.2

301.1

306

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

300.6

303

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

555.5

299.4

312

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

94.4

299.3

348

A02BC02

ATC

pantoprazole; systemic

2.0

293.7

9138

60136

A06AH03

ATC

naloxegol; oral

33.4

293.4

405

109

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

893.7

292.1

301

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.8

290.4

721

843

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

287.6

290

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

284.6

287

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

284.6

287

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

14.0

284.4

518

334

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

282.6

285

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

281.6

284

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.5

280.2

519

348

UJK02

NOMESCO Finland

ERCP

6.9

277.9

752

999

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

8.2

277.5

666

737

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

277.2

2112

7358

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

1261.2

273.2

280

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

12.1

272.2

530

397

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

502.5

270.7

283

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

270.1

6395

37522

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

360.6

269.4

285

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1235.1

268.2

275

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

1235.1

268.2

275

D77

ICPC

Malignant digestive neopl other/NOS

358.0

267.5

283

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

2341.9

267.3

272

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

608.3

263.5

274

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

1198.8

261.3

268

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

257.8

260

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

10.1

255.2

542

483

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

253.8

256

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

249.6

2671

11167

R50.9

ICD-10 Finland

Fever, unspecified

2.7

249.4

2052

7445

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

249.4

2724

11505

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.8

244.6

1162

2859

JFF10

NOMESCO Finland

Loop enterostomy

41.0

244.1

322

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

87.2

242.1

284

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

317.7

237.0

252

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

234.9

237

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

232.9

235

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1059.8

232.5

239

R18

ICD-10 Finland

Ascites

9.5

230.3

505

477

UJG02

NOMESCO Finland

Proctoscopy

6.8

230.1

627

838

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

9.5

228.2

502

477

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

226.9

229

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

225.9

228

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

224.9

227

C16.00

ICD-10 Finland

Cardia

+∞

224.9

227

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.3

219.7

571

712

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

44.8

217.6

282

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

9.5

216.8

477

453

L01BC59

ATC

trifluridine, combinations; systemic

+∞

215.0

217

176

Kela drug reimbursment

Regorafenib

+∞

215.0

217

ZXC96

NOMESCO Finland

Robot assisted procedure

15.7

214.8

373

213

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

56.5

214.5

267

R4110

NOMESCO Finland

Physiotherapy

2.0

214.3

3716

18991

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

33.0

214.1

296

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

213.0

215

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.1

212.5

900

1991

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

211.6

1797

6590

H01CB03

ATC

lanreotide; parenteral

281.4

209.5

224

JJB10

NOMESCO Finland

Atypcal resection of liver

388.2

208.5

220

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

278.8

207.5

222

J01MA12

ATC

levofloxacin; systemic

2.1

207.3

2720

12374

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

207.0

209

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

207.0

209

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

206.1

208

ZX080

NOMESCO Finland

Image guided radiotherapy

938.0

205.8

212

369

Kela drug reimbursment

Regorafenib

+∞

205.1

207

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

10.0

204.8

437

392

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

204.1

206

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

113.8

202.7

231

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

200.1

202

JFB43

NOMESCO Finland

Left hemicolectomy

22.9

199.8

304

118

L03AA14

ATC

lipegfilgrastim; parenteral

1721.1

198.8

203

L02BG04

ATC

letrozole; oral

24.4

198.1

296

108

JFB46

NOMESCO Finland

Resection of sigmoid colon

10.6

197.7

410

348

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

55.7

196.5

245

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

888.5

194.9

201

L02AE02

ATC

leuprorelin; implant, parenteral

23.4

194.3

294

112

HAC20

NOMESCO Finland

Total mastectomy

121.3

193.3

219

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

113.1

190.3

217

B01AB04

ATC

dalteparin; parenteral

3.6

186.7

940

2410

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

26.6

186.4

272

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

186.3

4510

25648

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

184.2

186

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

183.2

185

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

250.2

183.0

197

1XC07

NOMESCO Finland

+∞

182.2

184

E34.0

ICD-10 Finland

Carcinoid syndrome

161.7

181.7

201

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

181.2

183

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

26.2

180.9

265

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

17.3

180.2

301

155

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

179.7

1280

4200

D70.82

ICD-10 Finland

Drug-induced neutropenia

23.6

177.7

268

101

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

543.8

177.3

185

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

7.5

176.3

448

539

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

210.0

174.8

190

107

Kela drug reimbursment

Pernicious anaemia

5.4

174.7

569

953

Y77

ICPC

Malignant neoplasm prostate

133.4

174.5

196

H01CB02

ATC

octreotide; parenteral

93.6

172.9

201

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

172.3

174

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

171.3

173

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

171.3

173

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

170.3

172

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

170.3

172

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

169.3

171

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

168.8

1131

3561

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

168.3

170

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.5

168.3

472

654

JKA20

NOMESCO Finland

Cholecystectomy

4.5

167.7

650

1314

D76

ICPC

Malignant neoplasm pancreas

228.9

167.4

181

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

148.6

166.2

185

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

164.3

166

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

164.3

166

SPAT1125

SPAT

Stoma care and guidance

6.9

162.4

433

559

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.2

162.0

271

140

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

161.4

163

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

161.4

163

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

160.4

162

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.4

159.7

870

2366

Z51.0

ICD-10 Finland

Radiotherapy session

298.0

159.4

170

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

159.4

161

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

157.4

159

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

157.3

1525

5940

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

713.8

156.3

162

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

713.8

156.3

162

K56.7

ICD-10 Finland

Ileus, unspecified

6.6

155.0

427

577

L02BB03

ATC

bicalutamide; oral

472.1

153.7

161

A06AD11

ATC

lactulose; oral

2.0

151.2

2222

10436

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

11.9

149.9

292

218

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

147.5

149

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

147.5

149

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.3

146.5

825

2296

L01BC53

ATC

tegafur, combinations; systemic

+∞

145.5

147

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

8.4

144.6

341

364

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

144.5

146

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

143.9

1441

5691

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

142.7

914

2785

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

142.5

144

JAL30

NOMESCO Finland

Omentectomy

22.1

141.3

217

WX704

NOMESCO Finland

Intubation

2.7

140.4

1062

3594

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.4

140.3

747

1991

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.6

139.9

437

695

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

139.5

141

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

138.6

140

L01XE21

ATC

[U] regorafenib; oral

+∞

138.6

140

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

424.4

137.9

145

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

424.4

137.9

145

N02AX02

ATC

tramadol; systemic, rectal

1.6

137.3

5611

36164

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

19.9

137.3

218

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

136.6

138

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

136.6

138

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

135.6

137

198

Kela drug reimbursment

Sorafenib

+∞

135.6

137

C50.99

ICD-10 Finland

Breast, unspecified

415.5

135.0

142

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

255.2

134.0

144

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.3

133.3

207

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

14.6

133.2

237

144

L02BA01

ATC

tamoxifen; oral

54.2

132.7

166

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

132.6

134

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

132.6

134

K92.1

ICD-10 Finland

Melaena

2.8

131.5

930

3017

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

130.6

132

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

130.6

132

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

44.9

130.0

168

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.1

129.8

799

2363

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.2

129.4

758

2167

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

128.6

130

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

128.6

130

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

128.6

130

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

128.6

130

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.2

128.4

371

534

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.3

127.7

198

Z31.5

ICD-10 Finland

Genetic counselling

4.2

127.6

522

1109

JMA10

NOMESCO Finland

Transabdominal total splenectomy

20.6

127.4

200

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

78.4

127.3

151

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

126.5

455

849

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

35.9

126.5

171

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

34.0

126.3

173

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

59.3

125.8

155

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

125.7

127

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

124.7

126

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

1127.0

124.6

128

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

6.0

124.0

369

552

K83.0

ICD-10 Finland

Cholangitis

6.3

123.8

355

506

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

122.7

124

HA1AA

NOMESCO Finland

X-ray mammography

4.0

122.3

532

1196

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

12.2

122.2

235

171

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

41.2

121.1

159

A98

ICPC

Health maint/preventive medicine

0.6

120.7

10733

102973

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

131.1

119.3

134

Z93

ICD-10 Finland

Artificial opening status

37.1

119.2

160

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

118.3

899

3041

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

116.7

118

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

37.9

116.1

155

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

19.1

115.8

186

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.0

115.5

306

391

E0000UV

ATC

1.6

115.2

4753

30301

WX002

NOMESCO Finland

Sedation and analgesia

1.7

115.1

2734

15014

TPX15

NOMESCO Finland

Removal of vascular injection port

23.7

114.6

172

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

113.8

115

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

11.9

113.5

220

163

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

181.8

113.2

124

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.6

112.9

260

267

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

112.8

114

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

112.8

114

SPAT1109

SPAT

Analgesia with portable analgesic pump

17.8

112.3

185

R11

ICD-10 Finland

Nausea and vomiting

2.3

110.8

1096

4275

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

110.7

675

1979

N02BE01

ATC

paracetamol; systemic, rectal

1.6

109.2

11174

87227

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

108.8

110

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

67.9

108.5

131

SPAT1262

SPAT

Handing over of treatment supplies

1.7

108.3

2650

14643

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

107.8

109

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

107.8

109

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

107.8

109

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

107.8

109

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

106.6

579

1563

JDE00

NOMESCO Finland

Gastrojejunostomy

70.5

106.6

128

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

171.5

106.4

117

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

57.6

105.9

131

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

105.8

107

JLC10

NOMESCO Finland

Distal pancreatectomy

32.8

105.2

145

V03AF03

ATC

calcium folinate; systemic

247.3

104.1

112

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

247.3

104.1

112

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

103.9

668

2030

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

103.9

105

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

103.9

105

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

103.9

105

JGB36

NOMESCO Finland

Wide excision of rectum

930.7

102.9

106

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

930.7

102.9

106

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

9.1

102.6

229

223

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

921.9

101.9

105

L01AX03

ATC

temozolomide; systemic

+∞

101.9

103

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

101.9

103

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

913.0

100.9

104

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

100.9

102

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

+∞

99.9

101

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

99.9

101

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.6

99.2

777

2667

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

98.9

100

JJB71

NOMESCO Finland

Laparoscopic resection of liver

451.0

98.2

103

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

17.0

98.2

164

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

97.9

ZX121

NOMESCO Finland

Central venous catheter

31.3

96.9

135

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

96.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

95.9

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

95.9

ZZR00

NOMESCO Finland

Flap of skin

8.6

95.4

219

224

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

437.7

95.3

100

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

7.3

95.1

243

295

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

94.4

1175

5080

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

+∞

94.0

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.1

93.8

148

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

152.3

93.8

104

JJB30

NOMESCO Finland

Excision of two segments of liver

222.0

93.4

101

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

93.3

1048

4327

L01XE05

ATC

[U] sorafenib; oral

+∞

93.0

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.2

92.4

536

1516

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

+∞

92.0

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

92.0

C50

ICD-10 Finland

Malignant neoplasm of breast

175.7

91.2

100

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.6

91.2

440

1081

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

91.0

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.2

90.2

180

142

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

12.1

90.1

173

126

B81

ICPC

Anaemia vit B12/folate deficiency

2.7

89.7

660

2182

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

89.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

89.0

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

89.0

Z43.3

ICD-10 Finland

Attention to colostomy

38.4

88.8

118

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.5

88.4

335

660

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

88.0

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

88.0

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

88.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

59.2

87.8

108

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

87.0

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

87.0

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

87.0

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.1

86.6

225

280

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

85.5

474

1298

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

49.9

85.4

108

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

85.0

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

85.0

1CD01

NOMESCO Finland

+∞

85.0

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

10.9

84.8

171

138

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

87.0

84.8

D99

ICPC

Disease digestive system other

6.3

84.1

238

334

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

265.2

84.0

D74

ICPC

Malignant neoplasm stomach

199.7

83.7

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

7.4

83.5

211

252

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

28.3

83.5

119

JFB40

NOMESCO Finland

Resection of transverse colon

51.2

83.5

105

JN6AD

NOMESCO Finland

CT of torso and neck

12.6

83.2

157

110

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

83.1

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

83.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

82.4

429

1120

JFB50

NOMESCO Finland

Other resection of colon

22.0

81.7

125

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

16.3

80.9

137

ZX112

NOMESCO Finland

Subcutaneous

6.9

80.6

214

275

128

Kela drug reimbursment

Cancers of female genital organs

371.2

80.6

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

156.2

80.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

727.2

80.2

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

727.2

80.2

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

80.1

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

80.1

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

80.1

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

80.1

WX892

NOMESCO Finland

Monitored bed care

2.1

79.7

1038

4563

JF2AB

NOMESCO Finland

Colongraphy with X-ray

19.3

79.6

127

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.1

79.4

334

728

189

Kela drug reimbursment

Imatinib

718.4

79.2

JFB20

NOMESCO Finland

Ileocaecal resection

12.9

79.0

147

100

WX882

NOMESCO Finland

High dependency care

3.3

77.8

428

1165

XX1AD

NOMESCO Finland

Other CT-examination

150.9

77.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.4

77.4

412

1094

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

700.7

77.2

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

77.1

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

77.1

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.0

77.0

328

723

C25

ICD-10 Finland

Malignant neoplasm of pancreas

240.7

76.2

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

76.1

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

76.1

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

76.1

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.1

76.1

254

437

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

75.7

420

1150

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.0

75.6

221

324

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

75.5

272

509

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

75.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.8

75.0

152

124

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.2

74.9

419

1154

Z43.2

ICD-10 Finland

Attention to ileostomy

41.0

74.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

122.8

74.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

674.2

74.3

TJA10

NOMESCO Finland

Laparocentesis

46.3

74.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

74.2

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

74.2

JN4DD

NOMESCO Finland

Scout CT scan of torso

70.3

73.4

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

+∞

73.2

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

73.2

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

13.6

73.1

133

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

73.1

984

4379

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

175.4

73.0

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

21.4

72.7

112

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

23.4

72.7

109

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

64.4

72.6

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

47.5

72.3

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

72.2

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

72.2

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

72.2

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

140.3

71.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

71.6

2010

11389

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

71.2

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

70.2

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

70.2

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

70.1

499

1615

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

69.9

502

1634

N02AA01

ATC

morphine; systemic, rectal

6.5

69.8

193

263

Z93.2

ICD-10 Finland

Ileostomy status

14.1

69.8

125

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

69.6

609

2217

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6.5

69.5

191

258

J01MA02

ATC

ciprofloxacin; systemic

1.4

69.5

4725

32476

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.7

69.4

330

801

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.6

69.2

255

489

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.6

69.1

333

817

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

41.6

69.0

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

41.6

69.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

68.8

630

2348

X76

ICPC

Malignant neoplasm breast female

114.0

68.8

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

99.0

68.7

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

216.3

68.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

621.2

68.4

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

68.2

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

68.2

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

11.6

67.7

132

100

D18

ICPC

Change in faeces/bowel movements

3.4

67.0

346

898

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

14.4

66.6

118

L01XE01

ATC

[U] imatinib; oral

+∞

66.2

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

41.9

66.1

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

65.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

65.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

75.1

64.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

37.7

64.7

UJC12

NOMESCO Finland

Flexible oesophagoscopy

6.6

64.7

176

235

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.7

64.6

138

125

JJA20

NOMESCO Finland

Open biopsy of liver

22.1

64.3

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.2

63.9

151

163

UJF34

NOMESCO Finland

Left colonoscopy

6.6

63.8

173

230

WX004

NOMESCO Finland

Patient-controlled sedation

8.4

63.6

148

156

C15.0

ICD-10 Finland

Malignant neoplasm: Cervical part of oesophagus

+∞

63.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

63.3

ZX050

NOMESCO Finland

Stereotactic radiotherapy

22.2

63.1

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

5.6

63.0

195

308

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

291.4

63.0

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

151.2

62.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

62.2

224

420

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

15.4

62.1

107

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

18.9

61.9

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

61.3

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

+∞

61.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

61.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

61.3

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

+∞

61.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

60.8

903

4164

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.7

60.6

284

682

K65.0

ICD-10 Finland

Acute peritonitis

5.0

60.5

207

367

L02BX02

ATC

degarelix; parenteral

+∞

60.3

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

60.3

468

1594

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

10.6

59.5

121

100

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

59.3

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

42.2

59.3

JJB20

NOMESCO Finland

Excision of single segment of liver

186.9

58.7

KA1FN

NOMESCO Finland

Isotope renography

9.3

58.6

128

121

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

39.7

58.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.5

58.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

62.3

58.4

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

62.3

58.4

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

58.3

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

58.3

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

58.3

S18

ICPC

Laceration/cut

1.4

58.0

4964

35170

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

83.9

57.3

SPAT1255

SPAT

Intravenous administration of medicine

2.0

56.7

839

3864

L02BG03

ATC

anastrozole; oral

33.7

56.6

C03CA01

ATC

furosemide; systemic

1.4

56.4

3870

26385

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

56.3

JFF24

NOMESCO Finland

Laparoscopic transversostomy

178.1

55.8

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

135.8

55.6

SPAT1153

SPAT

Removal of sutures

1.4

55.4

3820

26052

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

55.4

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

55.4

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

15.4

55.3

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

50.4

54.9

N03AX16

ATC

pregabalin; oral

1.4

54.8

2762

17768

KCC10

NOMESCO Finland

Cystoprostatectomy

133.6

54.7

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

34.1

54.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

54.4

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

54.4

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

54.4

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

54.4

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

54.4

C10AA07

ATC

rosuvastatin; oral

0.7

53.7

1885

22728

C24.09

ICD-10 Finland

Biliary duct or passage NOS

489.0

53.6

JEA00

NOMESCO Finland

Appendectomy

2.1

53.6

644

2726

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

53.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

53.4

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

53.4

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

53.4

L01CB01

ATC

etoposide; systemic

+∞

53.4

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

53.0

644

2736

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

23.1

52.7

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

480.2

52.7

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

480.2

52.7

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.8

52.6

157

238

A28

ICPC

Limited function/disability NOS

1.5

52.5

1895

11345

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

52.4

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

52.4

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

52.4

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

52.4

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

52.4

191

Kela drug reimbursment

Erlotinib

+∞

52.4

KC1GB

NOMESCO Finland

Cystography with X-ray

19.2

52.2

M01AH05

ATC

etoricoxib; oral

0.8

52.2

5081

52431

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

10.9

51.9

104

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

471.4

51.7

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

103.3

51.7

M25.5

ICD-10 Finland

Pain in joint

0.7

51.6

1753

21287

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.2

51.5

121

130

323

Kela drug reimbursment

Sorafenib

+∞

51.4

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

51.4

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

51.3

772

3572

WW200

SPAT

0.5

51.3

392

6840

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

462.5

50.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

50.6

1305

7174

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

21.8

50.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

50.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

50.4

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

18.2

50.1

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

9.8

50.1

106

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

65.8

49.8

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

453.7

49.7

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

49.4

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

49.4

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

49.4

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

49.4

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

49.4

C24.00

ICD-10 Finland

Hepatic duct

+∞

49.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.8

49.3

119

134

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

42.4

48.7

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.2

48.6

268

732

C24.02

ICD-10 Finland

Common bile duct

+∞

48.4

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

48.4

UJD02

NOMESCO Finland

Gastroscopy

2.0

48.4

641

2825

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

13.3

48.3

R83

ICPC

Respiratory infection other

0.6

48.3

877

12118

K92.0

ICD-10 Finland

Haematemesis

2.7

48.2

358

1188

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

436.1

47.8

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.6

47.5

174

333

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

+∞

47.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

47.4

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

8.9

47.0

105

104

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

70.1

46.9

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.8

46.9

139

209

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

80.3

46.9

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

11.6

46.9

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.8

46.9

211

491

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

46.6

479

1889

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

15.2

46.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

46.5

C16.21

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

+∞

46.5

8249/3-C17.2

ICD-O-3

Neuroendocrine tumor, grade 2 of ileum

+∞

46.5

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

46.5

K56.0

ICD-10 Finland

Paralytic ileus

4.4

46.4

178

357

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

50.8

46.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

46.2

4270

30314

T73

ICPC

Neoplasm endocrine other/unspecified

38.1

46.2

WX110

NOMESCO Finland

Local anesthesy

1.3

46.2

7533

57938

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.5

45.6

223

556

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

45.5

564

2417

8145/3-C16.0

ICD-O-3

Carcinoma, diffuse type of cardia, NOS

+∞

45.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

45.5

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

45.5

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

+∞

45.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

45.5

K22.2

ICD-10 Finland

Oesophageal obstruction

4.4

45.3

172

342

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

111.6

45.1

UKC02

NOMESCO Finland

Cystoscopy

1.5

44.8

1763

10725

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

409.7

44.8

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

44.5

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

44.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

8.4

44.5

102

106

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

142.9

44.2

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

59.0

44.2

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

23.7

43.9

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

15.3

43.6

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

43.5

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

43.5

JFF26

NOMESCO Finland

Sigmoidostomy

22.8

43.3

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.7

43.2

155

291

6404

FHL

Hemicolectomy on the right

21.4

43.2

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

43.2

365

1305

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

29.2

42.8

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.6

42.8

337

1159

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

10.0

42.7

ZX100

NOMESCO Finland

Oral

3.9

42.6

187

426

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

42.5

792

3945

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

6.2

42.5

120

170

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

201.2

42.5

316

Kela drug reimbursment

Imatinib

+∞

42.5

8070/3-C15.5

ICD-O-3

Squamous cell carcinoma, NOS, of lower third of esophagus

+∞

42.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

42.5

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

+∞

42.5

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

42.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

42.5

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

105.0

42.2

XQ902

NOMESCO Finland

Other photography

7.1

42.1

108

134

SAA01

NOMESCO Finland

Simple examination of mouth

0.8

41.7

6138

60878

SPAT1088

SPAT

Blood transfusion

8.0

41.5

107

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

41.5

1XC08

NOMESCO Finland

+∞

41.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

41.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

41.5

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

134.2

41.3

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

102.8

41.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

41.1

837

4288

A41.8

ICD-10 Finland

Other specified sepsis

3.2

41.0

227

623

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

41.0

1673

19788

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

19.0

41.0

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

40.9

896

4693

197

Kela drug reimbursment

Sunitinib

+∞

40.5

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

40.5

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.1

40.4

103

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

5.5

40.3

126

203

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

38.6

40.3

M03BX02

ATC

tizanidine; oral

0.8

40.3

5400

54244

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

40.2

617

2872

L15

ICPC

Knee symptom/complaint

0.7

40.1

1374

16755

JFC00

NOMESCO Finland

Entero-enterostomy

21.4

40.0

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

365.6

39.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

39.8

1751

10885

C10AA05

ATC

atorvastatin; oral

0.8

39.8

3766

39479

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

35.7

39.7

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.9

39.6

260

803

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

39.5

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

+∞

39.5

C15.2

ICD-10 Finland

Malignant neoplasm: Abdominal part of oesophagus

+∞

39.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

39.5

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

39.5

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

39.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

39.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

39.5

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

39.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

39.5

WGA11

NOMESCO Finland

Planning of pain management

20.5

39.5

N05CF01

ATC

zopiclone; oral

1.3

39.4

3791

26922

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

68.6

39.4

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

39.2

5222

52565

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2175

6711

2.70

307.65

10.1

9.3

24.1

24.5

mmol/l

7.57

2116

6088

(40768804) Tissue Pathology biopsy report

9533

40741

2.51

307.65

2.7

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1833

4145

3.68

307.65

2.5

3.1

0.3

0.4

u/ml

3.50

963

2443

(4035726)

4841

3807

12.58

307.65

1.4

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9748

40890

2.60

307.65

3.8

2.3

56.5

60.2

u/l

5.09

9303

37283

(3042936) Bacteria identified in Isolate by Culture

4380

17621

2.18

307.65

2.2

2.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2618

8107

2.73

307.65

9.6

9.2

0.7

1.85

2608

8055

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1694

3757

3.74

307.65

1.5

1.4

197.8

281.4

ug/g

42.28

1075

2211

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

238

53.61

307.65

1.0

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

13590

77747

2.02

307.65

7.2

4.5

7.1

6.9

mmol/l

21.49

13146

72519

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14073

129713

0.54

307.65

4.2

4.8

1.4

mmol/l

21.03

12504

118609

(3000991) Gas panel - Venous blood

3185

10661

2.57

307.65

8.8

8.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8200

27725

3.14

307.65

3.2

2.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2953

8870

2.86

307.65

1.7

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8902

40513

2.24

307.65

7.5

2.1

2.3

2.4

mmol/l

20.85

8226

33561

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12206

65394

2.08

307.65

9.0

5.9

1.2

mmol/l

121.27

10442

54810

(3014111) Lactate [Moles/volume] in Serum or Plasma

3368

11270

2.58

307.65

7.7

6.9

1.3

1.4

mmol/l

3.29

3263

10830

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8471

38822

2.17

307.65

5.7

2.7

43.9

34.8

u/l

7.38

8179

36397

(3033658) Prothrombin time (PT) actual/Normal

8292

30484

2.85

307.65

6.5

3.6

85.1

86.9

8.43

8190

29647

(3024561) Albumin [Mass/volume] in Serum or Plasma

13634

54367

3.71

307.65

10.3

3.9

32.9

35.5

g/l

307.65

13203

49559

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3790

12395

2.69

307.65

9.0

8.0

115.4

122.8

g/l

89.68

3689

11937

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2406

7276

2.78

307.65

7.7

7.3

24.7

24.8

mmol/l

1.41

2391

7196

(3022948) Iron [Moles/volume] in Serum or Plasma

5593

20617

2.52

307.65

2.4

2.6

11.0

12.9

umol/l

52.91

5340

18839

(3044640) Blood type and Crossmatch panel - Blood

10182

36050

3.33

307.65

3.5

2.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5404

13094

3.98

307.65

4.5

2.3

16.5

7.9

umol/l

41.48

4987

11259

(3023368) Bacteria identified in Blood by Culture

9201

34758

2.89

307.65

5.5

4.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4164

10790

3.50

307.65

3.7

2.3

63.6

43.6

u/l

0.55

3744

9106

(3016502) Oxygen saturation in Arterial blood

3998

13738

2.57

307.65

8.7

7.5

96.6

95.1

37.63

3883

13218

(3013650) Neutrophils [#/volume] in Blood by Automated count

13496

67877

2.53

307.65

17.2

6.5

4.1

4.3

e9/l

12.72

12003

57899

(3014007) Fractional oxyhemoglobin in Arterial blood

2729

8109

2.87

307.65

9.5

9.3

94.9

93.3

30.43

2724

8083

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1001

473

17.27

307.65

6.1

1.2

195.2

81.9

nmol/l

9.51

994

463

(3003396) Base excess in Arterial blood by calculation

4214

15231

2.45

307.65

8.5

7.2

0.7

1.3

mmol/l

17.33

3550

11890

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7209

33151

2.06

307.65

2.4

2.3

3.6

3.0

mg/l

47.80

6323

28035

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14732

133801

0.53

307.65

4.7

5.4

2.6

2.7

mmol/l

41.43

13093

122650

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11296

59140

2.06

307.65

8.0

5.4

1.2

mmol/l

100.57

10617

52321

(3014576) Chloride [Moles/volume] in Serum or Plasma

5258

16241

3.03

307.65

9.3

6.7

104.9

104.2

mmol/l

16.60

5182

15812

(3021162) Amylase [Enzymatic activity/volume] in Specimen

315

28.64

307.65

2.8

2.5

1106.2

3013.4

u/l

0.52

283

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4216

15261

2.44

307.65

8.5

7.2

5.1

kpa

9.22

4075

14523

(3003694) ABO and Rh group [Type] in Blood

6527

29791

2.03

307.65

1.4

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12852

54696

3.14

307.65

5.6

3.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2591

8174

2.68

307.65

9.6

9.0

1.3

1.4

10.18

2579

8115

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5769

18885

2.90

307.65

4.9

2.6

0.8

mmol/l

59.71

5521

17230

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

5339

2703

20.29

307.65

5.5

2.0

3850.7

139.2

u/ml

2.63

4845

2193

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1538

1116

11.51

307.65

3.4

2.0

1808.5

837.6

u/ml

0.56

1524

1093

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14231

130849

0.53

307.65

4.3

4.8

4.4

4.6

mmol/l

43.03

12775

120437

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

734

689

8.57

307.65

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

7641

38921

1.83

307.65

3.6

3.1

64.2

96.6

e6/l

1.88

6008

29517

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3173

1572

18.35

307.65

5.1

1.9

1296.0

718.5

u/ml

0.67

2931

1410

(40758558) Short blood count panel - Blood

6251

28730

1.99

307.65

13.2

4.9

—

(3032080) INR in Blood by Coagulation assay

12324

55223

2.78

307.65

10.0

1.3

inr

7.00

3169

15115

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1585

678

19.63

307.65

5.4

1.6

12.2

4.5

nmol/l

1.49

1562

645

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

13132

7242

35.92

307.65

7.5

1.5

37.2

8.9

ug/l

8.15

11908

5478

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

752

712

8.50

307.65

2.3

1.3

20.1

21.2

ug/l

0.16

737

690

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5096

17751

2.63

307.65

2.3

2.7

19.3

22.6

40.29

4479

14832

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5298

18990

2.57

307.65

2.2

2.6

2.4

2.3

g/l

9.01

5050

17363

(3022145) Colonoscopy Study observation

5625

13433

4.09

307.65

1.5

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3368

12859

2.24

307.65

3.6

2.7

249.2

241.8

u/l

1.41

3209

11905

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5975

9747

6.28

307.65

3.1

2.1

0.2

g/l

8.52

5740

8812

(3002256) Pathology report gross observation

3875

10074

3.45

307.65

1.4

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

388

183

16.82

307.65

2.4

1.1

21.3

27.0

u/ml

0.37

372

167

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4229

16377

2.27

307.65

5.1

5.6

1.0

mmol/l

10.61

3996

15036

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2637

6761

3.33

307.65

9.5

10.2

—

(40768441) Liver Pathology biopsy report

818

512

12.92

307.65

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4216

15250

2.44

307.65

8.5

7.2

13.8

11.6

kpa

111.14

4070

14501

(3020779) Urea [Moles/volume] in Serum or Plasma

3461

11503

2.61

307.65

6.3

7.3

9.0

10.9

mmol/l

37.50

3306

10866

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

16236

98269

2.26

307.65

17.6

5.5

110.8

76.2

u/l

285.81

15815

90729

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14809

62616

3.85

307.65

16.0

3.9

14.5

12.1

umol/l

25.34

14492

58497

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5945

23164

2.40

307.65

7.8

2.2

2.5

mmol/l

61.76

5587

19672

(3030467) Casts [#/volume] in Urine by Automated count

7011

35798

1.79

302.71

3.5

3.0

0.7

0.5

e6/l

5.65

5408

26640

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

282

127

17.53

293.33

2.9

1.1

62.1

20.3

u/ml

3.00

277

116

(40768797) Stomach Pathology biopsy report

4166

18153

1.98

292.80

1.6

1.2

—

(3018418) pH of Serum or Plasma

7277

37956

1.76

288.93

5.2

3.4

7.4

0.78

1531

6651

(36304419) Bacteria [Presence] in Urine

6684

34344

1.76

276.89

3.4

3.0

—

(42870588) Differential panel, method unspecified - Blood

7797

41902

1.72

274.85

5.3

5.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1659

5071

2.68

266.92

2.1

1.9

2.1

ug/l

0.03

1502

4410

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13763

125360

0.58

263.71

3.9

4.3

1.3

mmol/l

1.59

12157

113642

(3037121) Protein [Mass/volume] in Urine

1464

4250

2.81

259.48

5.2

2.7

0.2

0.4

g/l

5.10

1039

1512

(3026782) Osmolality of Urine

5163

24977

1.81

259.12

3.1

2.7

539.9

547.5

mosm/kgh2o

1.66

4585

20890

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

224

21.78

254.01

3.4

2.0

80.9

69.2

pmol/l

0.30

191

(3019069) Monocytes/100 leukocytes in Blood

9843

57485

1.63

242.61

5.9

6.0

9.1

8.8

10.87

9248

53092

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1293

3640

2.89

241.96

3.3

1.5

91.1

29.0

u/ml

11.35

1256

3447

(3018095) Leukocytes [#/volume] in Urine

8139

45408

1.65

239.91

4.1

3.5

122.3

113.9

e6/l

0.26

6205

31939

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4499

21295

1.82

239.79

1.9

1.8

—

(3006504) Eosinophils/100 leukocytes in Blood

9788

57195

1.62

239.67

5.7

2.6

3.0

42.04

9189

52605

(3022096) Basophils/100 leukocytes in Blood

9540

55567

1.62

235.05

5.7

5.8

0.6

0.7

42.25

8949

51160

(3002030) Lymphocytes/100 leukocytes in Blood

9978

58798

1.61

234.05

5.9

5.8

23.4

27.3

193.83

9313

53975

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4321

20338

1.83

233.76

3.2

2.7

e6/l

0.03

2406

10894

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8803

50333

1.62

233.29

3.0

2.8

150.8

137.7

ug/l

2.57

8172

45856

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4322

20462

1.81

228.75

2.2

2.0

30.3

30.0

2.53

4230

19820

(3023183) Ammonium ion [Moles/volume] in Plasma

1054

2732

3.11

227.25

3.0

2.6

37.5

33.3

umol/l

4.09

886

2312

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

264

180

11.57

222.42

2.7

2.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1099

3010

2.95

215.45

2.4

2.5

3.5

3.6

g/l

0.46

1059

2856

(4281824)

445

620

5.70

214.52

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

9745

58108

1.57

208.42

5.7

60.6

57.7

83.40

9144

53615

(3027945) Reticulocytes/100 erythrocytes in Blood

3335

15056

1.86

202.89

2.1

2.2

1.8

2.19

2983

13048

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14096

125412

0.63

196.05

6.7

6.4

41.7

40.6

mmol/mol

28.20

12790

115226

(40768795) Lymph node Pathology biopsy report

283

261

8.56

195.05

1.2

1.1

—

(3006315) Basophils [#/volume] in Blood

10186

62064

1.54

191.86

5.5

0.0

e9/l

25.06

8584

52999

(3031040) Bacteria [#/volume] in Urine by Automated count

13143

84759

1.56

190.90

4.9

4.5

2057.0

1513.1

e6/l

0.40

208

1314

(3001604) Monocytes [#/volume] in Blood

10121

61686

1.54

189.46

5.5

0.6

e9/l

11.16

8526

52648

(3000850) Epithelial cells [#/volume] in Urine

5184

27033

1.66

188.97

2.8

2.5

5.6

5.0

e6/l

2.68

4611

23389

(3019198) Lymphocytes [#/volume] in Blood

10314

63361

1.53

184.10

5.6

1.7

1.9

e9/l

8.08

8876

55056

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14828

129982

0.63

183.55

4.8

5.0

6.2

6.1

mmol/l

38.17

13313

117620

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

231

183

9.94

177.12

1.3

1.1

—

(3013115) Eosinophils [#/volume] in Blood

10358

64094

1.51

175.22

5.8

5.7

0.2

e9/l

28.10

8889

55514

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2824

12866

1.82

163.84

3.7

3.8

5.7

5.8

kpa

18.14

2735

12484

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1141

3677

2.50

162.93

1.3

1.2

—

(3026008) Bacteria identified in Urine by Culture

6892

39625

1.53

160.65

3.3

3.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1867

7445

2.05

160.61

1.6

1.5

—

(3002032) Base excess in Venous blood by calculation

2805

12845

1.81

159.72

3.7

3.8

1.8

1.9

mmol/l

0.64

2238

10506

(3012544) pH of Venous blood

2892

13403

1.79

158.13

3.7

3.8

7.4

0.06

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3124

14810

1.76

158.12

1.8

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4335

22469

1.64

157.38

3.0

2.6

1.2

e6/l

0.83

2404

12924

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

691

1731

3.18

156.94

1.2

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3106

14830

1.74

152.88

1.8

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

291

376

6.10

150.97

1.7

2.3

7113.1

2249.5

e6/l

0.70

205

260

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1001

3156

2.55

149.34

2.1

2.2

81.1

89.6

19.74

974

2917

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2080

8867

1.92

147.44

8.4

7.1

24.5

24.6

mmol/l

0.73

1969

8270

(3033799) Differential panel - Peritoneal fluid

259

316

6.46

141.75

1.7

2.3

—

(3019060) Gas panel - Arterial blood

2142

9382

1.87

139.38

6.1

4.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

925

2903

2.55

139.17

2.2

2.5

222.7

192.9

16.25

886

2730

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1059

3561

2.39

137.58

1.8

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

2451

11285

1.78

135.45

2.2

69.6

69.3

e9/l

0.13

1841

8565

(1617658) Protocol used for examination of sentinel lymph nodes

55.42

131.50

1.1

1.0

—

(3039000) Anion gap in Blood

916

2950

2.49

130.51

8.6

6.7

11.0

11.4

mmol/l

2.38

833

2674

(3018572) Chloride [Moles/volume] in Blood

916

2951

2.48

130.41

8.6

6.7

106.0

104.8

mmol/l

10.20

833

2675

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

250

330

5.97

127.09

1.6

2.2

9673.6

15176.2

e6/l

0.33

146

169

(3007930) Methemoglobin/Hemoglobin.total in Blood

1454

5747

2.04

127.01

6.8

4.8

0.9

0.60

1360

5414

(3010370) Gastrin [Moles/volume] in Serum or Plasma

164

129

9.98

126.36

2.4

1.5

65.6

51.4

pmol/l

0.50

136

105

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1470

5850

2.03

126.02

6.7

4.8

1.6

1.7

0.86

1376

5516

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13699

119655

0.69

124.49

4.4

4.7

2.5

2.1

mu/l

0.65

12145

108163

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

611

1645

2.95

122.70

6.1

6.2

12.0

11.9

mg/l

0.11

552

1494

(3047181) Lactate [Moles/volume] in Blood

1148

4204

2.19

121.99

7.7

5.8

1.4

1.3

mmol/l

2.20

1016

3750

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1503

6121

1.98

120.66

3.8

4.2

23.9

24.2

mmol/l

1.57

1403

5419

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

579

1565

2.94

115.44

1.2

1.1

1.7

1.5

g/l

9.66

543

1393

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1797

7907

1.84

114.14

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2623

13085

1.64

106.44

4.8

3.3

—

(3044007) Cell count panel - Peritoneal fluid

220

307

5.64

105.90

1.7

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2084

9854

1.72

103.27

1.4

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10967

98311

0.73

103.26

3.7

3.9

15.0

14.9

pmol/l

1.13

9720

88095

(3024354) Oxygen [Partial pressure] in Venous blood

2229

10757

1.69

102.45

3.3

3.1

4.5

kpa

0.18

2144

10399

(1761868) Lipid panel - Serum or Plasma

3958

42052

0.67

102.23

3.0

3.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3398

37075

0.66

99.93

1.7

1.4

mmol/l

2.50

2888

30620

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2184

10552

1.68

99.79

1.4

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

220

327

5.29

99.23

1.9

1.5

1.9

2.0

umol/l

0.68

207

305

(3004809) Band form neutrophils/100 leukocytes in Blood

548

1565

2.78

98.86

2.6

2.9

2.1

1.3

4.14

425

1175

(3007566) Smooth muscle Ab [Titer] in Serum

889

3251

2.18

94.40

1.3

1.2

76.9

138.4

titre

1.95

278

(3034770) Mitochondria Ab [Titer] in Serum

876

3261

2.14

88.90

1.3

1.2

332.2

1104.2

titre

—

103

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2106

10413

1.64

87.38

5.0

3.1

1.2

mmol/l

5.92

1948

8785

(3036489) Thrombin time

1051

4238

1.98

86.06

2.1

1.9

21.9

21.7

0.25

994

3711

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

582

1842

2.51

85.72

5.4

6.0

2364.7

892.3

iu/ml

0.51

102

283

(3000963) Hemoglobin [Mass/volume] in Blood

17317

143041

0.68

84.63

45.9

20.0

124.5

136.4

g/l

307.65

17075

140277

(3026361) Erythrocytes [#/volume] in Blood

17316

143020

0.68

84.30

45.6

19.9

4.2

4.5

e12/l

307.65

16837

137658

(3010813) Leukocytes [#/volume] in Blood

17318

143033

0.68

84.28

45.6

19.9

7.1

6.7

e9/l

45.02

16846

137687

(3024731) MCV [Entitic volume]

17316

143014

0.68

84.15

45.5

19.8

91.2

91.4

7.31

17077

140238

(3018405) Lactate [Moles/volume] in Arterial blood

1183

5005

1.89

84.09

4.7

4.2

1.4

mmol/l

0.13

1163

4905

(3035941) MCH [Entitic mass]

17315

142990

0.69

83.75

45.4

19.8

30.1

30.4

105.27

17071

140225

(3023436) Glucagon [Mass/volume] in Serum or Plasma

16.45

83.19

1.8

1.5

187.2

203.8

ng/l

0.62

(3007461) Platelets [#/volume] in Blood

17313

142943

0.69

82.96

45.7

19.9

250.0

244.6

e9/l

15.96

16897

138181

(40768800) Prostate Pathology biopsy report

372

952

3.08

81.45

1.2

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1368

6214

1.77

77.14

1.4

1.6

1.7

1.6

g/l

4.34

1178

5272

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1875

22072

0.63

75.47

1.2

1.3

44.1

40.1

iu/ml

0.41

598

6893

(3025941) Bacteria identified in Stool by Culture

1406

6483

1.74

75.21

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1737

20771

0.62

74.86

1.2

1.3

17.5

14.5

u/ml

0.44

624

7586

(40768793) Breast Pathology biopsy report

293

698

3.31

72.08

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

469

1481

2.50

69.40

1.4

1.5

32.0

30.0

g/l

2.27

418

1297

(40768806) Pleura Pathology biopsy report

369

1033

2.82

69.09

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

1962

10065

1.57

69.04

3.3

3.8

1.1

0.8

5.27

833

2151

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

203

386

4.13

68.79

2.9

2.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

175

296

4.64

68.46

1.4

1.6

13.3

12.8

g/l

0.26

140

212

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

206

407

3.98

66.41

1.9

1.4

27.8

29.0

umol/l

0.85

200

390

(3037467) Urinalysis macro (dipstick) panel - Urine

12840

89830

1.29

65.64

5.1

4.3

—

(3021589) Normoblasts [#/volume] in Blood

8342

55280

1.29

64.82

16.1

8.7

0.0

e9/l

0.68

6682

45285

(3023199) Leukocytes [#/volume] in Pleural fluid

421

1329

2.50

62.36

1.4

1.5

1707.6

3380.2

e6/l

1.27

305

977

(3012501) Base excess in Blood by calculation

732

2912

1.99

62.05

4.7

4.1

2.9

2.6

mmol/l

1.93

534

1984

(3022217) INR in Platelet poor plasma by Coagulation assay

3440

20124

1.40

61.99

21.9

28.2

1.4

inr

1.42

505

2693

(3013290) Carbon dioxide [Partial pressure] in Blood

732

2914

1.99

61.93

4.7

4.1

5.0

kpa

0.72

719

2835

(3027315) Oxygen [Partial pressure] in Blood

734

2937

1.98

61.20

4.7

4.1

9.0

8.4

kpa

7.92

721

2857

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

95.20

60.85

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11561

80222

1.27

60.44

4.8

3.0

106.7

49.4

u/l

147.65

10916

73386

(3004119) Hemoglobin [Mass/volume] in Venous blood

1721

8829

1.57

60.17

3.3

119.8

130.5

g/l

62.99

1684

8613

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1154

5354

1.72

60.06

2.0

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

478

1631

2.31

59.75

1.4

164.7

80.7

pmol/l

3.65

469

1595

(3028308) Erythrocytes [#/volume] in Pleural fluid

385

1190

2.55

59.57

1.4

1.5

76314.7

59080.1

e6/l

0.30

237

720

(3051651) Icteric interference index of Serum or Plasma

252

621

3.19

58.82

5.3

4.1

—

(3010421) pH of Blood

806

3384

1.89

58.34

4.5

4.0

7.4

0.95

719

2835

(3020891) Body temperature

1205

5702

1.69

58.31

5.5

4.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2634

14875

1.44

57.54

1.8

—

(3012441) Differential panel - Pleural fluid

362

1111

2.57

56.84

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

422

1403

2.37

55.94

2.4

2.8

2697.7

7503.5

u/ml

0.30

(3021440) Promyelocytes/100 leukocytes in Blood

1833

9693

1.52

55.69

3.3

3.8

0.2

0.1

4.06

764

2010

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

104

7.00

55.12

6.3

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1249

6053

1.65

55.10

1.3

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

145

253

4.49

54.76

1.2

1.6

36.0

47.8

g/l

0.19

111

193

(3045788) Cell count panel - Pleural fluid

335

1018

2.59

53.68

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1360

6775

1.60

53.66

2.9

2.8

1.2

0.37

1349

6743

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1056

4935

1.70

53.42

1.9

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

681

2795

1.93

52.74

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1326

6626

1.60

51.61

2.8

0.7

2.74

1294

6341

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

640

2603

1.95

50.90

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

620

2496

1.97

50.79

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

175

374

3.67

50.75

3.1

3.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1730

9249

1.50

49.64

3.1

3.6

0.8

0.6

2.75

568

1593

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

661

2746

1.91

49.37

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

548

7930

0.53

47.20

1.2

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

489

1858

2.08

46.98

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1474

7726

1.52

46.35

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

837

3816

1.74

46.20

4.4

3.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1379

7158

1.54

45.32

3.5

3.3

24.8

25.3

mmol/l

6.09

1330

6945

(3036782) Glucose [Moles/volume] in Pleural fluid

309

990

2.45

44.47

1.3

6.4

6.6

mmol/l

0.86

290

907

(3019225) pH of Specimen

2344

13553

1.39

43.92

4.6

3.7

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.55

43.14

1.9

2.8

55.2

60.0

0.36

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

424

1577

2.12

43.09

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

433

1627

2.10

42.86

1.5

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4372

27790

1.29

42.75

3.8

4.0

417.1

595.2

ng/l

1.34

3675

22862

(3025468) Yersinia sp identified in Specimen by Organism specific culture

418

1551

2.12

42.74

1.5

1.3

—

(1616796) Gas panel - Central venous blood

658

2862

1.82

42.58

3.6

3.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

422

1576

2.11

42.44

1.5

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

618

8377

0.56

42.35

1.8

1.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

418

1557

2.12

42.32

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

417

1552

2.12

42.31

1.5

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

5165

33548

1.27

42.30

1.7

1.5

20.4

nmol/l

0.03

4584

28260

(3045142) Bone marrow Pathology biopsy report

285

904

2.48

41.92

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

327

5370

0.47

41.23

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

551

2309

1.88

40.11

1.5

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

296

978

2.38

39.90

1.3

519.5

396.8

u/l

0.23

278

911

(3025159) Blasts/100 leukocytes in Blood

1661

9209

1.44

39.24

3.4

3.8

0.1

0.2

0.14

626

1747

(3043409) Potassium [Moles/volume] in Arterial blood

894

4357

1.63

38.37

4.9

4.5

3.8

3.9

mmol/l

4.66

841

4101

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6580

44303

1.23

38.16

2.9

3.1

1543.8

1537.1

ng/l

0.04

5782

38022

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

659

2974

1.75

37.69

4.2

2.8

1.7

mg/l

0.22

611

2646

(3019309) Folate [Moles/volume] in Red Blood Cells

4407

28440

1.26

37.29

1.8

1181.5

1161.1

nmol/l

0.67

3391

21274

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17034

138479

0.79

37.03

37.7

15.8

80.6

umol/l

0.03

17023

138420

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

622

2777

1.77

36.92

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

622

2778

1.77

36.87

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1307

7017

1.48

36.39

3.0

2.6

0.5

0.3

e6/l

3.06

1294

6847

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

212

624

2.67

36.33

2.2

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1248

6645

1.49

36.19

4.3

3.9

47.1

47.7

0.36

1234

6564

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

514

2199

1.84

35.11

3.5

3.3

59.2

58.4

0.68

514

2199

(3049717) Cytology report of Urine Cyto stain

902

4512

1.58

34.75

2.9

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1487

8312

1.42

33.43

2.5

2.3

10.7

10.8

g/l

0.74

1346

7551

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17052

138318

0.80

33.17

20.9

9.4

28.5

26.1

u/l

23.82

16691

132103

(3003338) MCHC [Mass/volume]

12829

106958

0.83

32.77

41.0

17.9

329.2

332.4

g/l

249.51

12701

106048

(40760892) CBC W Ordered Manual Differential panel - Blood

3961

25646

1.25

31.84

4.4

4.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

389

1569

1.95

31.80

1.6

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

144

4.51

31.73

4.2

1.5

72.1

64.5

u/l

0.09

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

303

1118

2.13

31.55

2.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

123

287

3.36

31.52

2.1

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

292

1066

2.15

31.24

2.4

2.8

61.9

61.3

0.15

174

688

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

243

822

2.32

31.19

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

283

1022

2.17

31.10

1.6

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1878

11073

1.35

30.56

2.4

1.6

64.3

66.8

g/l

30.95

1695

9869

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7899

54965

1.19

30.55

3.9

3.8

46.6

78.5

ng/l

2.54

6344

39831

(1002224) Polysomnography panel

288

4451

0.50

30.39

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

600

2802

1.69

30.38

2.6

2.5

15.1

16.5

9.86

282

1470

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

160

447

2.80

30.34

2.1

2.0

—

(40761536) Microorganisms panel - Urine sediment

1740

10159

1.37

30.13

4.4

4.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

316

1213

2.05

29.69

1.5

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

5.76

29.45

1.7

2.8

24.1

14.8

0.83

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

236

810

2.29

29.33

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1804

10648

1.35

29.09

4.1

2.4

64.5

62.6

ml/min/173m2

1.21

806

4178

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

816

4159

1.55

28.97

2.4

2.9

—

(3024928) Oxygen saturation in Venous blood

616

2941

1.65

28.70

2.6

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

370

1521

1.91

28.65

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

337

1342

1.97

28.63

4.8

3.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1265

13463

0.72

27.70

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

300

1160

2.03

27.68

2.7

3.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

161

479

2.63

27.16

1.9

15.7

15.5

0.05

211

(3028026) IgM [Mass/volume] in Serum or Plasma

1184

6592

1.42

27.10

1.9

1.5

1.4

1.2

g/l

1.41

1076

5971

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

217

745

2.28

26.99

1.4

1.8

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

5.97

26.90

1.7

1.2

2397.2

197.4

u/l

0.86

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

138

382

2.83

26.68

1.3

1.4

55.5

63.8

1.69

113

304

(3028271) Lactate [Moles/volume] in Capillary blood

463

2089

1.74

26.59

1.9

1.8

1.7

mmol/l

0.65

457

2044

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

202

679

2.33

26.38

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

162

491

2.58

26.36

2.0

1.9

72.3

71.4

0.30

157

467

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

217

756

2.25

26.10

1.3

13.0

12.5

u/l

0.12

194

682

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

201

682

2.31

25.71

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

695

3518

1.56

25.46

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

212

740

2.25

25.40

1.1

—

(3035880) pH of Pleural fluid

185

609

2.38

25.34

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

689

3486

1.56

25.29

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

122

325

2.94

25.27

1.4

2.5

2.6

0.04

103

267

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

198

3.55

25.27

1.9

2.1

—

(3011412) CD3 cells [#/volume] in Blood

199

681

2.29

24.98

2.2

2.1

1.1

e9/l

0.24

138

358

(42529406) Shigella sp [Presence] in Stool by Culture

694

3532

1.55

24.82

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

181

597

2.38

24.70

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

181

597

2.38

24.70

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

597

2944

1.60

24.46

3.7

2.9

8.1

7.9

kpa

0.81

552

2737

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

659

7721

0.65

24.26

1.2

1.3

55.4

51.9

au/ml

0.14

333

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

746

8516

0.67

24.11

2.3

2.4

28.5

29.6

au/ml

0.06

352

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

23.61

1.1

0.0

—

(3013512) EKG study

5980

41353

1.18

23.04

4.4

4.1

—

(3008037) Lactate [Moles/volume] in Venous blood

658

3366

1.54

23.02

3.7

3.2

1.7

1.6

mmol/l

1.09

646

3294

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

377

1686

1.76

22.40

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

414

1903

1.71

22.32

2.8

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

554

6610

0.64

22.23

1.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

365

1627

1.76

21.94

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

8.33

21.88

1.7

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

255

3.04

21.80

1.9

2.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2006

12487

1.28

21.77

1.4

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

237

920

2.02

21.75

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7860

67023

0.86

21.62

2.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

174

600

2.27

21.54

2.0

2.1

37.6

44.9

1.04

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

402

1860

1.70

21.19

1.3

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

12.82

20.58

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

415

1954

1.67

20.51

1.7

1.6

0.9

g/l

0.02

305

1473

(3009343) pH of Capillary blood

1438

8639

1.32

20.36

3.7

3.5

7.4

0.11

195

1057

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1455

8760

1.32

20.29

3.7

3.5

5.1

5.2

kpa

4.11

1340

8035

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

454

5538

0.63

20.17

1.6

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1673

10293

1.29

19.85

2.6

1.8

410.6

367.4

nmol/l

11.25

1565

9296

(3038515) Glucose [Moles/volume] in Venous blood

616

3211

1.51

19.80

3.9

3.3

7.7

7.8

mmol/l

0.14

608

3145

(3000919) Neutrophils/100 leukocytes in Pleural fluid

106

301

2.75

19.69

1.4

27.2

22.1

0.90

268

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2076

13130

1.26

19.66

3.0

220.1

224.4

ng/l

0.17

1895

12030

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1387

8332

1.32

19.64

3.7

3.5

2.0

1.8

mmol/l

0.50

1001

6160

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

427

2049

1.64

19.63

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

402

5004

0.62

19.53

1.5

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

273

3745

0.56

19.48

1.4

1.7

4.2

3.7

mg/l

0.37

223

2659

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.58

19.42

1.1

1.0

2.7

3.0

ug/l

0.08

(3008898) HLA-B27 [Presence]

222

3227

0.53

19.37

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

384

1803

1.67

19.21

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5121

44775

0.86

18.98

2.1

2.2

232.8

225.9

u/l

0.14

4804

41660

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

171

618

2.17

18.98

1.5

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

264

2.84

18.93

1.2

1.3

672.1

38.7

ug/l

1.44

119

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

361

1675

1.69

18.89

1.3

1.5

102.3

117.5

u/ml

2.04

362

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

344

1577

1.71

18.81

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

170

616

2.16

18.75

1.5

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8319

59658

1.14

18.56

2.2

2.0

88.7

95.1

pmol/l

30.14

4955

30394

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

392

1872

1.64

18.39

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

635

7092

0.69

18.22

1.2

1.3

211.8

240.1

u/ml

0.52

563

6560

(3003181) Sodium [Moles/volume] in Urine

490

2476

1.56

18.19

1.4

1.3

58.4

63.7

mmol/l

1.99

355

1980

(1761482) Bacteria [#/volume] in Urine by Culture

712

3892

1.44

18.04

5.0

4.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

246

1036

1.86

17.90

1.5

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1397

13792

0.77

17.79

1.4

—

(4094501)

317

4076

0.60

17.67

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

1020

1.86

17.57

1.6

1.4

—

(3021901) Oxygen saturation in Capillary blood

495

2538

1.53

17.23

3.0

2.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

144

506

2.23

17.16

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

274

1212

1.77

17.03

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

731

2.00

16.96

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

414

4958

0.64

16.94

1.1

1.2

1.9

0.8

u/ml

0.51

457

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.34

16.62

2.3

4.4

1.4

1.5

mg/l

0.03

(3044242) Glucose [Moles/volume] in Arterial blood

175

673

2.04

16.61

2.8

1.8

—

(3022475) Manganese [Moles/volume] in Blood

5.95

16.56

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

525

2.18

16.48

1.6

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

525

2.18

16.48

1.6

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

525

2.18

16.48

1.6

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

1104

1.80

16.47

1.6

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

225

949

1.86

16.34

1.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

225

949

1.86

16.34

1.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

225

949

1.86

16.34

1.5

1.3

—

(3019977) pH of Arterial blood

196

792

1.94

16.20

3.5

2.4

7.4

0.33

271

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

279

1263

1.73

16.04

1.1

1.2

66.5

57.4

u/l

0.59

205

815

(40761511) CBC panel - Blood by Automated count

16618

133487

0.86

16.02

28.7

13.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

145

527

2.15

15.95

1.6

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

1633

1.64

15.90

1.4

—

(44806118)

265

1192

1.74

15.59

1.4

1.5

—

(44790047)

265

1193

1.74

15.55

1.4

1.5

—

(44790048)

265

1193

1.74

15.55

1.4

1.5

—

(44790049)

265

1193

1.74

15.55

1.4

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

193

788

1.92

15.50

1.4

13.1

13.4

u/l

0.24

188

755

(3024471) HLA-A [Type]

110

362

2.38

15.29

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

112

3.63

15.21

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

102

325

2.45

15.20

1.3

1.4

3.6

3.2

mmol/l

0.36

293

(4010399)

1026

10331

0.76

15.16

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1596

15234

0.80

15.14

1.3

1.4

—

(3024932) HLA-DR beta [Type]

108

356

2.37

14.97

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

114

385

2.32

14.97

1.7

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

114

386

2.31

14.88

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

115

392

2.29

14.79

1.7

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

527

2832

1.46

14.68

1.2

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

252

2.64

14.67

1.2

1.4

21.6

25.8

0.63

206

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.92

14.53

1.6

1.2

—

(3042631) Mycobacterium sp identified in Specimen

340

1667

1.60

14.46

2.3

2.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16987

128568

1.16

14.42

30.7

13.6

37.2

24.0

mg/l

307.65

15948

101065

(3048689) Calprotectin [Mass/mass] in Stool

2106

13791

1.21

14.20

1.9

2.2

241.5

143.0

ug/g

16.61

1702

10674

(4034850)

423

4853

0.67

14.06

14.1

10.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

339

4059

0.65

13.91

1.6

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

386

2.25

13.67

3.0

2.5

32.9

42.5

3.18

137

(3020717) Zinc [Moles/volume] in Serum or Plasma

129

477

2.12

13.67

1.8

1.4

30.5

21.7

umol/l

1.92

122

446

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

276

2.49

13.61

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

110

383

2.25

13.51

5.5

1.2

35.6

282.8

u/ml

3.87

(3000494) Fungus identified in Specimen by Culture

2259

14971

1.20

13.38

1.6

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

200

2676

0.58

13.15

1.5

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

105

3.50

13.10

1.2

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

322

2.33

12.87

2.2

2.0

35607.8

37768.5

u/ml

0.02

(40765096) Chromosome analysis panel by Banding

171

2.88

12.86

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1954

17994

0.83

12.85

4.2

4.9

33.0

32.6

0.70

1275

12050

(3015235) Bicarbonate [Moles/volume] in Capillary blood

626

3557

1.38

12.83

3.1

24.3

24.9

mmol/l

2.62

542

3140

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1180

0.38

12.83

1.0

34.5

44.7

ng/l

1.59

790

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.73

12.82

1.2

1.4

0.9

ml/s/173m2

1.61

(3052592) Norovirus Ag [Presence] in Stool

247

2.53

12.80

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

5376

45880

0.88

12.75

3.2

3.3

413.6

319.7

mg/l

0.83

3617

29029

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1176

0.38

12.73

1.0

649.0

718.7

ng/l

0.86

771

(3019832) Treponema pallidum Ab [Presence] in Serum

392

4474

0.68

12.71

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

163

674

1.89

12.71

3.0

2.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1171

0.38

12.61

1.0

261.1

331.2

ng/l

2.27

800

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

327

1650

1.55

12.38

1.3

1.2

321.0

293.4

u/ml

0.77

212

1078

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

343

1750

1.54

12.36

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

155

2.92

12.19

1.4

12.3

9.4

0.31

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

137

542

1.98

12.17

1.8

1.4

3.9

3.8

mg/l

0.05

129

515

(3010375) cycloSPORINE [Mass/volume] in Blood

127

489

2.03

12.16

30.4

28.5

119.8

115.6

ug/l

0.32

104

402

(3000475) Leukocytes [#/volume] in Synovial fluid

334

3897

0.66

12.14

1.6

16907.0

14303.8

e6/l

0.38

237

2841

(3023103) Potassium [Moles/volume] in Serum or Plasma

17209

137366

0.87

12.01

35.8

16.5

4.0

mmol/l

46.32

16904

133298

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

173

745

1.82

11.91

1.5

5.6

6.3

u/l

0.24

335

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

845

5087

1.31

11.83

2.2

2.3

498.4

633.5

ug/l

0.51

814

4781

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

301

3552

0.66

11.59

1.6

1.7

45.2

43.5

nmol/l

0.40

284

3420

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

138

558

1.93

11.54

2.3

2.1

512.5

918.6

e6/l

1.49

263

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3959

27713

1.14

11.48

1.8

1.7

2.1

1.2

mg/l

26.23

3263

21327

(3048929) Epstein Barr virus Ab [Presence] in Serum

432

2352

1.44

11.35

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

176

2336

0.58

11.29

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

155

2.82

11.10

1.4

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

122

480

1.99

11.06

2.0

3.1

16.2

25.9

mu/l

2.84

114

450

(3037522) Nuclear Ab [Titer] in Serum

1845

16859

0.84

11.04

1.3

470.2

555.6

titre

1.25

394

3727

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

223

2.49

11.04

2.2

1.4

24.1

36.2

u/l

0.66

199

(3020682) Albumin/Creatinine [Ratio] in Urine

5733

48427

0.89

11.01

4.0

11.5

8.6

mg/mmol

3.07

3739

30655

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

143

2.89

10.99

1.3

54.6

268.0

u/l

0.45

(40761539) Cells [Type] in Urine sediment by Light microscopy

286

2.30

10.96

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

536

1.93

10.94

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

132

536

1.93

10.94

1.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

479

2679

1.40

10.85

1.5

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

302

3508

0.67

10.79

1.2

1.3

40.0

40.5

u/ml

0.01

208

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

132

2.96

10.77

1.4

76.1

65.4

1.56

107

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

192

2452

0.61

10.59

1.1

1.2

51.9

48.2

u/ml

—

255

(3007164) IgA [Mass/volume] in Serum or Plasma

3113

21557

1.15

10.50

1.5

1.3

2.8

2.6

g/l

2.25

1834

12281

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

180

816

1.73

10.49

2.4

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

176

793

1.74

10.48

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

368

1986

1.45

10.18

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

17197

137013

0.88

10.16

35.8

16.4

138.9

139.8

mmol/l

300.81

16913

133165

(3022313) Gas panel - Capillary blood

1004

6301

1.25

10.12

3.9

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

493

2808

1.38

10.06

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

5551

46785

0.90

10.00

3.2

7.3

7.5

mmol/l

1.81

4547

39121

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

349

2.10

10.00

1.6

1.3

1651073.6

1652082.1

iu/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

169

2.63

9.98

1.4

1.3

1.6

1.3

mmol/l

0.17

(3004716) Salmonella sp identified in Stool by Organism specific culture

807

4944

1.28

9.94

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

205

978

1.64

9.91

1.9

1.7

1395.2

2376.2

u/l

0.31

362

(3009466) Valproate [Moles/volume] in Serum or Plasma

144

1935

0.58

9.75

3.8

4.7

329.4

357.2

umol/l

1.39

119

1634

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

253

1275

1.55

9.74

1.3

1.4

nmol/l

0.86

225

1156

(3000060) B lymphocytes [#/volume] in Blood

149

2.73

9.72

1.9

1565.4

157.2

e6/l

0.78

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.05

9.60

1.7

1.1

2.0

1.4

pmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

397

4294

0.72

9.60

1.4

—

(3004451) EKG impression Narrative

155

692

1.75

9.57

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

105

414

1.98

9.53

2.1

5.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

109

3.01

9.36

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

1138

7306

1.23

9.34

4.8

3.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

159

721

1.72

9.31

1.2

330.4

371.7

u/l

0.18

148

667

(3037756) Immunofixation for Serum or Plasma

466

2671

1.37

9.19

1.5

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

157

715

1.72

9.07

1.2

42.1

22.8

u/l

2.47

136

602

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

287

3249

0.68

9.04

1.2

1.3

6.5

6.4

u/ml

0.01

545

(3026250) Tacrolimus [Mass/volume] in Blood

113

466

1.90

9.03

36.5

35.2

6.9

7.3

ug/l

2.01

100

426

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

218

1082

1.58

9.01

1.3

1.2

31.2

121.5

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

218

1083

1.58

8.98

1.3

1.2

126.7

175.9

titre

0.61

194

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

161

742

1.70

8.92

1.2

159.0

86.8

u/l

1.97

142

638

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

195

946

1.61

8.87

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4346

31036

1.12

8.77

1.8

1.7

17481597.3

32248272.0

pmol/l

1.16

3581

25242

(3006184) Hemoglobin [Mass/volume] in Capillary blood

539

3184

1.33

8.74

2.3

2.2

120.9

131.0

g/l

15.24

404

2310

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

112

1561

0.56

8.73

1.1

4.5

1.2

u/ml

0.72

623

(3022493) Free Hemoglobin [Mass/volume] in Plasma

127

550

1.81

8.73

2.3

5.4

60.1

1545.2

mg/l

1.33

380

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

285

3207

0.69

8.70

1.2

1.3

6.2

5.9

u/ml

0.04

356

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

106

2.95

8.64

2.5

1.2

66.5

102.4

ng/l

1.19

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

368

3957

0.72

8.62

1.5

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.90

8.53

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

496

2908

1.34

8.48

1.4

1.5

0.8

nmol/l

0.63

429

2394

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

141

1833

0.60

8.46

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

187

2270

0.64

8.37

1.7

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1349

0.54

8.35

1.0

1.1

1.7

1.2

u/ml

0.41

527

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15335

122630

0.91

8.29

30.7

12.5

77.9

76.4

ml/min/173m2

16.82

13646

98817

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

304

3350

0.70

8.27

1.8

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

231

2.23

8.20

2.2

1.9

12.5

9.5

0.72

213

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

684

6701

0.79

8.18

1.1

1.2

135.4

133.1

iu/ml

0.05

211

2523

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2112

18659

0.87

8.10

12.4

7.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.43

8.06

3.7

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1383

0.56

7.84

1.0

1.1

7.0

3.3

u/ml

0.82

640

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

849

5398

1.24

7.70

4.1

3.8

24.8

24.9

mmol/l

0.53

763

4925

(3041096) Erythrocytes [Presence] in Urine by Automated

4576

32990

1.10

7.56

4.3

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

279

3068

0.71

7.54

1.3

563.5

553.4

mg/l

0.11

273

2901

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

997

0.49

7.50

1.2

1.4

82.2

104.6

pmol/l

0.28

299

(3036603) Volume of Urine

159

768

1.62

7.45

1.7

1.4

1788.9

1934.5

0.67

187

(3019150) Specific gravity of Urine by Refractometry

3476

29620

0.90

7.32

4.5

4.3

1.0

kg/l

0.38

597

4467

(3021788) Differential panel - Synovial fluid

257

2847

0.70

7.27

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

520

1.74

7.19

2.3

2.0

520.1

512.5

e6/l

0.03

446

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.85

7.17

1.2

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

8650

64281

1.08

7.13

5.6

5.0

0.0

estimate

0.44

1887

11134

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

180

906

1.55

7.11

1.1

1.0

294.8

286.7

mg/l

0.63

162

812

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

271

2962

0.71

7.10

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

593

1.69

7.06

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

8749

65068

1.08

7.04

4.2

3.8

0.0

estimate

0.36

1853

10783

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

111

495

1.75

7.02

2.4

2.0

0.2

e9/l

0.31

439

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

802

1.58

6.89

1.3

1.4

1.0

1.3

nmol/l

2.65

130

606

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

230

2568

0.69

6.83

1.7

1.9

193.0

198.0

pmol/l

0.38

216

2411

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

159

786

1.58

6.81

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

177

903

1.53

6.62

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

138

2.43

6.55

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1018

0.53

6.46

1.0

4.7

3.2

u/ml

0.32

404

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

145

713

1.59

6.38

1.7

1.9

2.4

u/field

0.01

113

474

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

261

2817

0.72

6.38

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1511

10297

1.16

6.33

3.6

3.9

94.1

94.9

ng/l

0.12

1325

8677

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

12.26

6.22

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

214

1157

1.45

6.07

2.0

2.1

2.3

2.1

u/field

0.17

420

(3014271) Vancomycin [Susceptibility]

162

830

1.53

5.99

2.8

3.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

839

0.51

5.96

1.0

1.3

0.6

u/ml

—

210

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1170

0.58

5.93

1.0

4.0

1.8

u/ml

0.46

276

(3035350) Ketones [Presence] in Urine by Test strip

8612

64300

1.07

5.89

4.1

3.8

0.0

estimate

0.80

1859

10923

(3000093) Morphology [Interpretation] in Blood Narrative

211

1147

1.44

5.83

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

441

1.72

5.82

3.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

441

1.72

5.82

3.0

2.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

252

2687

0.73

5.76

1.2

3.9

mmol/l

0.10

239

2527

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

251

2678

0.73

5.76

1.4

248.7

1617.8

e6/l

5.48

203

2218

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

251

2675

0.73

5.72

1.4

14.5

24.8

e6/l

0.92

194

2101

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

124

605

1.60

5.69

1.1

97.9

83.4

u/l

0.87

105

466

(3017732) Neutrophils [#/volume] in Blood

1263

8564

1.16

5.69

4.1

2.9

4.3

4.1

e9/l

1.70

973

6248

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

108

509

1.66

5.68

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

256

2713

0.73

5.63

1.1

1.2

3.6

5.8

u/ml

0.49

220

(44813793)

832

0.52

5.61

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

315

1.83

5.55

1.3

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

155

802

1.51

5.52

1.4

1.5

13.2

13.7

umol/l

0.30

146

754

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

123

607

1.58

5.41

1.1

38.7

21.8

u/l

1.74

446

(40760888) Immunoglobulin light chains.free panel - Serum

513

3221

1.25

5.34

2.4

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.45

5.34

1.1

0.8

u/field

1.23

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.61

5.25

1.2

1.1

1.0

0.6

u/field

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

101

480

1.64

5.19

1.7

5.7

9.4

nmol/l

0.32

397

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

180

1991

0.70

5.19

1.5

62.0

59.5

0.34

107

1280

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

577

1.58

5.18

1.7

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

165

2.13

5.14

2.4

1.2

—

(3014891) Appearance of Pleural fluid

176

2.08

5.10

1.7

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

126

1480

0.66

5.02

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

657

4269

1.21

4.95

2.6

1.6

1.7

2.1

ratio

0.40

348

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

675

4400

1.20

4.92

2.6

1.6

55.7

36.7

mg/l

0.55

557

3547

(3028300) Cannabinoids [Presence] in Urine

173

1906

0.71

4.90

1.5

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1395

9633

1.14

4.88

2.1

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

233

1.91

4.88

1.3

1.2

1.5

mmol/l

0.17

121

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

382

3755

0.79

4.86

1.5

1.6

5.1

3.0

iu/ml

0.23

103

836

(3044941) Cell count panel - Synovial fluid

231

2426

0.74

4.85

1.4

—

(3027008) Opiates [Presence] in Urine

173

1902

0.71

4.84

1.5

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

274

1610

1.33

4.82

8.0

12.6

7.4

7.6

mmol/l

0.61

234

1317

(44786800) Granulocytes/100 leukocytes in Body fluid

129

2.24

4.79

1.4

1.3

35.3

27.2

0.59

(3023430) Cat dander IgE Ab [Units/volume] in Serum

949

0.59

4.78

1.0

4.1

3.3

u/ml

0.22

370

(3000764) Benzodiazepines [Presence] in Urine

173

1895

0.71

4.75

1.5

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

675

4416

1.20

4.74

2.6

1.6

64.4

47.1

mg/l

1.14

557

3567

(21494434) Karyotype in Bone marrow

174

952

1.43

4.74

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

279

2841

0.76

4.72

1.3

—

(3008295) Osmolality of Serum or Plasma

212

1207

1.37

4.60

1.2

1.4

275.2

277.0

mosm/kgh2o

0.53

167

902

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.41

4.60

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

1543

0.69

4.57

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.76

4.57

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

130

1486

0.68

4.55

1.5

26.5

28.3

0.23

940

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

153

2.09

4.53

1.4

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

214

1225

1.37

4.50

1.4

0.4

g/l

0.02

139

862

(3016879) Cocaine [Presence] in Urine

161

1766

0.71

4.48

1.5

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

214

1226

1.36

4.48

1.4

6.8

6.9

g/l

0.13

139

858

(3028192) IgG subclass 2 [Mass/volume] in Serum

214

1226

1.36

4.48

1.4

3.0

g/l

0.08

139

859

(4062490)

213

1222

1.36

4.43

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

129

1468

0.68

4.42

1.5

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

234

2413

0.75

4.38

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

266

1581

1.32

4.37

1.4

1.2

—

nmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

376

1.66

4.36

1.3

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

10.40

4.35

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

10.40

4.35

1.1

1.0

48.4

20.2

umol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

500

0.47

4.34

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

128

1450

0.69

4.30

1.2

7.6

mmol/l

0.01

105

1021

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.45

4.29

1.1

—

(3044889) 12 lead EKG panel

12425

94477

1.06

4.26

4.5

4.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

722

0.56

4.25

1.1

—

(3027944) Amphetamines [Presence] in Urine

173

1856

0.72

4.23

1.5

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

805

5404

1.17

4.22

2.0

1.4

3.8

3.9

g/l

0.82

562

3819

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

807

5420

1.17

4.21

2.0

1.4

7.6

7.5

g/l

0.90

587

3961

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

806

5415

1.17

4.19

2.0

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

123

648

1.48

4.13

2.5

2.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.60

4.12

1.9

2.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

295

1795

1.29

4.10

1.4

1.2

0.7

2.1

nmol/l

0.94

279

1720

(3004616) Nuclear Ab [Presence] in Serum

155

1682

0.72

4.09

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

113

2.21

4.07

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

298

1819

1.28

4.04

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

274

1655

1.29

4.03

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

107

1236

0.67

4.01

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.93

3.98

1.1

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

844

0.61

3.96

1.3

0.3

1.3

u/ml

4.21

452

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

428

0.45

3.93

2.4

2.6

147.2

146.5

nmol/l

0.01

370

(3010144) Erythrocytes [#/volume] in Synovial fluid

141

1543

0.71

3.93

1.4

1.3

106165.0

142706.5

e6/l

0.33

1065

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

155

1670

0.72

3.93

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

753

5062

1.17

3.91

2.1

1.5

3.2

3.1

g/l

3.92

573

3902

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

486

1.54

3.91

1.1

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

4783

35397

1.07

3.87

4.4

4.2

0.0

estimate

0.23

1694

10740

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

105

1207

0.68

3.86

1.0

1.1

—

29.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

294

1804

1.27

3.85

1.4

1.2

0.2

0.3

nmol/l

0.86

138

(3001964) Herpes simplex virus Ag [Presence] in Specimen

294

1.70

3.84

1.4

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

142

1545

0.71

3.83

1.1

9.3

11.4

au/ml

—

(3011288) Drugs identified in Urine by Screen method

105

1205

0.68

3.83

1.6

2.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

129

1426

0.70

3.83

1.9

2.1

1.8

5.8

titre

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

271

1.73

3.82

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

336

1.65

3.82

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

682

4562

1.17

3.78

1.6

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.81

3.72

1.0

1.1

36.3

36.1

0.05

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.81

3.72

1.0

1.1

8.5

9.0

0.28

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.81

3.72

1.0

1.1

21.1

22.0

0.29

(21494890) Protein electrophoresis panel - 24 hour Urine

218

1293

1.32

3.70

1.9

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

104

543

1.50

3.69

2.9

1.9

212.2

205.0

u/l

0.25

104

537

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1009

0.66

3.69

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

230

1.76

3.58

1.9

1.1

2.0

2.4

ug/l

0.30

158

(3008536) Aspergillus sp Ab [Presence] in Serum

197

1.82

3.52

1.8

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

758

0.62

3.47

1.2

1.1

51.5

42.7

mg/l

0.66

643

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1932

13860

1.10

3.45

2.2

2.4

5.1

8.0

ug/l

12.14

1625

12003

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

154

1.93

3.44

1.8

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

281

2736

0.80

3.42

1.6

1.8

5.5

7.7

iu/l

0.28

931

(3045716) Anion gap in Serum or Plasma

127

701

1.42

3.42

2.4

2.3

9.2

9.0

mmol/l

0.21

508

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.40

3.41

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

329

1.61

3.40

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

110

592

1.45

3.39

2.3

1.6

40.0

9.8

umol/l

2.61

424

(3039162) Centromere protein B Ab [Units/volume] in Serum

146

1547

0.73

3.39

1.1

1.2

32.6

52.5

u/ml

—

112

(3047189) Immunofixation for 24 hour Urine

447

1.52

3.37

1.6

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.90

3.34

6.5

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1829

13111

1.10

3.33

1.8

1.6

1.5

1.45

1553

11244

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

745

5074

1.15

3.31

2.0

1.4

10.3

g/l

0.09

618

4201

(3000012) Reticulocyte production index

131

732

1.40

3.30

1.2

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

115

628

1.43

3.30

2.6

2.7

—

25.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

117

642

1.42

3.27

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

327

2075

1.23

3.26

1.7

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

559

1.45

3.25

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7091

53344

1.05

3.24

2.4

2.2

74.9

78.7

nmol/l

23.42

6388

46674

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

684

0.61

3.20

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

102

1133

0.70

3.18

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

593

3984

1.17

3.18

2.2

1.5

0.1

0.0

g/l

0.60

527

3604

(3016038) Potassium [Moles/volume] in Urine

162

945

1.34

3.15

1.3

1.1

35.2

33.9

mmol/l

0.30

147

783

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

108

589

1.43

3.14

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

306

1.61

3.13

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

503

0.56

3.12

1.1

136.2

765.0

ng/l

—

122

(3026493) Urate [Moles/volume] in Serum or Plasma

4484

36644

0.94

3.11

3.0

2.5

4047.5

5474.2

umol/l

1.51

3839

31164

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

106

1163

0.71

3.09

1.0

1.1

—

57.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.39

2.93

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

432

0.54

2.91

1.3

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

222

1.69

2.90

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

370

0.51

2.90

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

370

0.51

2.90

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

370

0.51

2.90

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

370

0.51

2.90

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

142

1.87

2.87

1.3

1.2

52.1

116.4

ug/l

4.26

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

659

4500

1.15

2.87

2.2

1.5

0.8

0.5

g/l

2.01

558

3796

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.90

2.87

1.4

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

563

3804

1.16

2.84

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5204

42250

0.95

2.84

4.1

3.7

21.6

24.0

24.65

2567

20147

(3035320) C reactive protein [Mass/volume] in Body fluid

152

896

1.33

2.80

2.7

2.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

550

3717

1.16

2.78

2.2

1.5

0.0

g/l

0.62

484

3348

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

716

0.65

2.77

1.1

367.3

288.3

mg/l

0.87

637

(3006270) Folate [Moles/volume] in Blood

202

1239

1.27

2.77

1.3

1.2

340.4

340.2

nmol/l

0.00

159

1001

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

649

0.64

2.76

1.1

9.9

10.3

iu/ml

—

131

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

122

1.92

2.75

1.1

22.6

18.2

u/l

0.42

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

615

0.63

2.67

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

662

0.65

2.66

5.1

5.0

46.9

462.8

u/ml

—

116

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

296

0.47

2.65

3.3

3.0

6.8

7.1

mg/l

0.08

241

(3002619) Bacteria identified in Specimen by Culture

259

1.60

2.63

1.3

—

(40762814) Titanium [Mass/volume] in Blood

335

0.51

2.59

2.2

2.3

3.3

ug/l

—

120

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

126

736

1.34

2.51

2.2

42.3

137.8

ug/min

1.97

175

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

974

0.72

2.50

1.1

—

41.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

771

0.69

2.47

1.1

1.9

6.0

nmol/l

1.40

159

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

116

1205

0.75

2.47

1.5

1.8

2586.7

2370.8

titre

—

(3007916) DNA double strand Ab [Titer] in Serum

176

0.40

2.46

1.0

1.2

—

97.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

488

3306

1.15

2.44

3.1

0.8

nmol/l

0.58

383

2570

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.35

2.43

1.4

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

111

1.90

2.43

1.7

1.1

1.0

mmol/l

0.05

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

212

1332

1.24

2.42

3.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

3.51

2.42

2.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

513

0.62

2.40

1.2

1.3

59.4

57.3

0.13

441

(3015736) pH of Urine

6667

50384

1.05

2.39

3.8

3.6

5.9

5.4

1.79

(3051101) Glucose [Moles/volume] in Cord blood

345

0.54

2.38

5.6

6.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.15

2.36

5.7

1.4

—

(3024263) Appearance of Synovial fluid

828

0.71

2.36

1.4

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

156

948

1.29

2.36

1.2

11.8

12.1

mmol/l

0.21

285

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

613

4230

1.13

2.35

2.1

1.5

36.3

37.5

g/l

4.44

514

3553

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

109

1133

0.75

2.35

1.2

31.0

47.1

u/ml

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.95

2.34

1.0

1.1

7.3

14.7

iu/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.34

2.31

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

123

0.32

2.31

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

536

0.64

2.30

1.1

1.9

1.0

u/l

0.57

257

(3026470) Cobalt [Mass/volume] in Blood

109

1127

0.75

2.27

1.8

2.0

3.7

3.8

ug/l

0.06

998

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

533

3655

1.14

2.26

2.2

1.5

0.0

g/l

0.00

481

3336

(3034891) Synovial lining cells/100 cells in Synovial fluid

738

0.70

2.25

1.5

1.9

4.3

1.60

163

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

533

0.64

2.25

1.2

1.1

—

(4027681)

542

0.65

2.24

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

357

0.57

2.22

1.1

1.0

0.1

1.6

u/ml

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

115

1.83

2.21

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

115

1.83

2.21

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

115

1.83

2.21

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

409

3676

0.86

2.20

1.4

1.6

0.2

g/l

0.06

382

3476

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

510

0.64

2.18

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

895

0.73

2.16

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

894

0.73

2.15

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

151

1.71

2.15

2.0

2.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

893

0.73

2.14

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.97

2.13

1.4

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

230

0.47

2.12

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

1.87

2.11

1.4

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

2.10

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

890

0.73

2.10

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

890

0.73

2.10

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

438

0.62

2.09

1.1

—

(3025577) Chromium [Mass/volume] in Blood

107

1092

0.76

2.07

2.0

2.1

2.2

2.3

ug/l

0.22

913

(3009542) Hematocrit [Volume Fraction] of Blood

14356

113397

0.96

2.06

32.7

15.0

36.6

39.6

208.05

9376

74675

(40759836) Histone Ab [Presence] in Serum by Immunoblot

887

0.74

2.06

1.1

1.2

—

(40763590) HLA-DQ beta [Type]

3.64

2.05

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

593

0.68

2.01

1.3

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

323

0.58

1.94

1.5

1.9

10.0

9.0

mg/l

0.44

259

(40760409) HLA-A [Type] by High resolution

3.41

1.94

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

3.41

1.94

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

3.41

1.94

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

156

1.65

1.94

2.0

2.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.30

1.92

1.2

1.4

124.1

142.7

ug/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

423

3749

0.88

1.91

1.5

1.2

g/l

1.00

397

3544

(3028679) Herpes simplex virus Ab [Presence] in Serum

484

0.66

1.91

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

112

0.35

1.91

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

511

0.67

1.89

1.2

1.3

40.5

39.9

g/l

0.09

274

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

239

0.52

1.86

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

880

0.75

1.86

2.0

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

385

3424

0.87

1.84

1.7

1.9

12.1

11.3

mg/l

0.56

352

3169

(3013862) HLA-DP [Type]

3.21

1.83

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

688

0.72

1.80

1.1

1.3

1.5

g/l

—

(3016750) Collection duration of Urine

141

882

1.25

1.77

2.1

497.9

500.7

min

0.11

663

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.14

1.77

1.5

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

579

1.31

1.77

5.2

6.4

24.7

25.3

mmol/l

0.53

525

(3028707) Methadone [Presence] in Urine by Screen method

899

0.76

1.76

1.6

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

512

0.68

1.76

1.2

1.1

32.5

8.6

u/ml

—

(40757373) Influenza virus identified in Isolate

261

1.46

1.76

1.4

1.7

—

(3000492) Spirometry study

1379

11474

0.93

1.73

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

141

0.44

1.72

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

349

0.63

1.71

1.4

1.5

—

(3023419) Bacteria identified in Sputum by Culture

261

1741

1.17

1.70

2.4

2.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

190

0.49

1.69

1.2

1.3

3.4

6.6

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3405

25533

1.05

1.69

1.2

1.3

2.3

1.7

u/ml

1.07

827

6695

(3012565) Volume of 24 hour Urine

101

611

1.29

1.68

1.9

1676.5

1971.6

2.85

530

(3029396) Erythrocyte agglutination [Presence] in Blood

1.98

1.68

1.9

2.3

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

0.3

0.8

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

3.1

1.9

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

0.5

2.4

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

0.1

0.8

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

1.0

2.7

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

0.2

1.8

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.16

1.68

1.7

1.4

1.9

3.5

mg/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3658

29582

0.96

1.66

3.0

2.7

0.8

0.7

ug/l

4.14

2552

19974

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

103

0.38

1.65

1.4

1.9

0.8

1.6

mg/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

250

2271

0.86

1.64

1.3

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

765

0.75

1.64

1.8

1.4

7.6

5.9

u/l

0.34

650

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

383

0.65

1.64

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

177

0.48

1.63

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

272

1.43

1.63

1.2

16.7

16.5

umol/l

0.19

249

(3025018) Bordetella pertussis Ab [Titer] in Serum

576

0.72

1.63

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

630

0.73

1.63

1.2

1.1

ratio

0.02

214

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

126

1216

0.81

1.61

1.5

1.6

24.6

25.9

u/ml

0.12

276

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

337

2303

1.14

1.61

3.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.18

1.59

1.1

1.0

258.8

292.8

nmol/l

0.24

(3048879) Bone marrow aspiration report

313

1.40

1.58

1.5

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.36

1.57

1.4

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

130

1246

0.81

1.57

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.07

1.54

1.7

1.4

0.8

1.4

mg/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

460

0.69

1.53

1.1

1.0

2.8

1.5

u/ml

0.29

140

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

300

0.62

1.51

1.3

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

264

1.42

1.50

2.3

2.7

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.99

1.50

1.1

1.4

1.1

1.0

u/field

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

106

1031

0.80

1.48

1.2

1.3

84.0

454.5

titre

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

633

5394

0.91

1.48

1.7

1.9

39.7

38.8

u/l

0.45

556

4675

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

297

0.63

1.46

1.5

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

189

0.54

1.45

1.1

1.2

—

90.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

301

1.37

1.40

1.1

1.3

2.1

3.0

umol/l

1.58

274

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

486

0.72

1.38

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.92

1.37

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

289

1.38

1.37

1.0

1.1

75.0

87.9

1.06

151

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

205

0.57

1.36

1.4

2.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

430

0.71

1.35

1.1

1.0

0.9

0.6

u/ml

—

105

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

328

0.67

1.34

1.6

154.2

118.4

ng/l

0.55

328

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

186

1.47

1.33

1.1

1.2

75.7

126.2

ng/l

0.99

128

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

195

1303

1.17

1.32

1.3

—

38.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

195

1304

1.17

1.31

1.0

1.1

5.1

3.9

u/ml

0.31

503

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.40

1.30

1.5

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.83

1.30

1.7

1.2

0.1

g/l

—

(3014051) Protein [Presence] in Urine by Test strip

434

3060

1.11

1.30

2.3

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

279

1.37

1.29

2.7

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.80

1.25

3.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.95

1.24

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

189

1268

1.16

1.24

2.2

2.3

717.7

665.4

0.77

107

865

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

256

0.64

1.23

1.4

1.7

143.5

57.4

au/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

119

767

1.21

1.23

1.4

1.3

33.1

33.4

u/l

0.03

560

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.00

1.21

1.1

1.4

3.9

2.1

0.36

(3000034) Microalbumin [Mass/volume] in Urine

205

1390

1.15

1.18

3.1

3.0

38.6

45.7

mg/l

0.21

149

989

(3006653) Thiamine [Moles/volume] in Blood

100

637

1.23

1.17

1.1

1.2

132.5

139.4

nmol/l

0.69

100

637

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.84

1.17

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

417

0.73

1.16

1.5

1.4

—

(3028433) Virus identified in Specimen by Culture

380

1.29

1.16

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

120

0.52

1.16

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

353

0.71

1.15

1.6

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

1.15

0.0

1.1

—

25.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

458

0.75

1.11

1.1

94.2

99.2

0.46

355

(3025130) Human papilloma virus identified in Specimen

103

966

0.83

1.09

1.5

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

215

1.38

1.08

1.5

1.6

94.9

120.5

ug/l

1.25

177

(3050129) First trimester maternal screen panel - Serum or Plasma

464

0.76

1.08

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4171

31697

1.03

1.07

3.6

3.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.58

1.07

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

463

0.76

1.06

1.4

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.70

1.05

8.0

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.70

1.05

4.0

3.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

110

718

1.20

1.04

2.0

1.9

—

(3006462) Nitrate [Presence] in Urine

101

655

1.20

1.02

3.7

3.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

107

993

0.84

1.02

1.2

1.3

122.9

60.7

titre

—

(3041184) Isoniazid [Presence] in Urine

2.29

1.02

2.0

2.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

670

1.20

1.01

3.8

3.9

—

(3023410) Appearance of Cerebral spinal fluid

123

1126

0.85

1.01

1.5

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

313

1.30

1.01

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

158

0.59

1.00

1.5

2.0

16.8

18.0

umol/l

0.14

158

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

254

2211

0.89

1.00

1.3

1.2

66.1

25.4

u/l

1.99

223

1894

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.99

0.0

5.5

—

0.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

333

0.73

0.99

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

612

0.80

0.97

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.68

0.96

2.2

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

180

1.39

0.96

1.2

1.1

—

(4211845)

108

710

1.19

0.96

3.6

3.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

137

919

1.16

0.96

1.5

1.7

69.9

71.5

umol/l

—

(3018291) Platelet Ab [Presence] in Serum

2.34

0.96

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

507

0.78

0.95

2.3

3.0

29.7

28.7

umol/l

0.26

383

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

471

0.78

0.94

1.1

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

256

0.70

0.92

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

182

1.37

0.91

2.5

2.8

0.8

0.5

u/field

0.87

182

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

0.58

0.91

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

120

801

1.17

0.91

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

119

794

1.17

0.91

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

442

0.78

0.91

1.0

1.1

1454.3

1616.6

miu/ml

0.47

442

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

172

0.63

0.90

1.3

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

544

1.20

0.90

1.5

1.8

129.5

109.7

umol/l

0.16

276

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.47

0.90

1.2

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

2.03

0.87

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

289

0.73

0.87

1.1

—

(3001729) Color of Synovial fluid

132

0.59

0.87

1.1

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

342

1.25

0.86

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

198

1.34

0.85

1.1

5.2

3.1

pmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

178

1.36

0.85

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

205

1.33

0.85

1.0

1.2

81.3

83.7

0.12

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

376

0.77

0.85

1.2

114.0

137.4

nmol/l

0.61

263

(3032868) Hemoglobin electrophoresis panel in Blood

0.53

0.84

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

366

0.77

0.83

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

284

2021

1.10

0.81

1.1

3932.5

6215.7

iu/ml

0.13

392

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

207

1.32

0.81

1.1

1.2

83.6

74.5

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.80

0.0

1.6

—

111.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

194

0.68

0.80

1.2

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

297

1.26

0.80

1.0

1.1

77.6

87.0

0.78

152

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

118

0.59

0.80

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

363

0.77

0.79

1.4

1.6

0.3

0.4

ug/l

0.09

225

(3009214) Lutropin [Units/volume] in Serum or Plasma

289

2061

1.09

0.79

1.4

1.3

14.5

9.2

u/l

5.82

222

1641

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.50

0.79

1.4

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

446

1.21

0.78

1.7

196.6

160.3

2.48

415

(3034614) HLA Ag [Interpretation]

0.00

0.78

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

388

0.78

1.3

1.4

—

(3022621) pH of Urine by Test strip

1207

9029

1.04

0.77

3.2

3.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

421

3055

1.08

0.77

1.1

4.8

9.2

u/ml

1.47

285

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

387

0.79

0.76

1.3

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

106

0.59

0.74

1.3

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

385

0.79

0.74

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

385

0.79

0.74

1.3

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.05

0.73

4.0

1.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

556

0.83

0.73

1.2

57.1

56.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

136

1.38

0.73

1.8

2.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.60

0.71

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

322

0.77

0.71

1.9

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.95

0.71

4.0

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

255

1821

1.09

0.70

1.9

2.1

36.6

26.6

mg/l

1.08

487

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

171

1.32

0.70

1.1

—

(4015189)

442

0.81

0.70

1.8

2.5

—

(44806420)

488

1.18

0.70

2.4

2.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

312

0.77

0.69

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

133

1168

0.89

0.68

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.65

0.67

1.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

319

0.78

0.67

1.3

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

292

2104

1.08

0.67

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

826

6738

0.95

0.66

3.1

3.0

4.2

4.4

pmol/l

5.21

728

5880

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

249

1.25

0.66

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

261

1873

1.09

0.66

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

222

1891

0.91

0.65

1.1

1.3

184.1

209.3

miu/ml

0.40

754

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

791

0.87

0.65

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

316

0.79

0.63

1.3

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

157

0.70

0.63

1.2

1.1

11.7

8.0

mg/g

0.46

146

(3017400) Magnesium [Moles/volume] in Urine

1.70

0.62

1.2

1.0

2.9

2.2

mmol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

203

1.27

0.61

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

108

0.65

0.61

1.0

—

3.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.61

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.61

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.61

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.61

0.0

1.3

—

285.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

128

0.67

0.60

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

164

0.71

0.60

2.4

1.6

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

197

1.27

0.59

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

330

0.80

0.59

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.42

0.59

1.6

1.4

22.5

22.6

mmol/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

665

1.14

0.59

1.1

5.0

4.0

iu/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

318

1.20

0.58

2.7

2.5

7.9

mmol/l

0.01

199

(40768443) Skin Pathology biopsy report

650

5306

0.95

0.57

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

126

0.68

0.56

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

0.73

0.56

3.8

4.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

185

1320

1.09

0.56

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.37

0.53

1.2

1.1

11.2

11.0

u/l

0.01

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

151

0.72

0.53

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

0.69

0.53

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

138

1.30

0.53

2.0

1.7

50.3

45.6

umol/l

0.38

138

(3003577) Lead [Moles/volume] in Blood

0.62

0.53

1.0

1.3

—

0.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

104

0.67

0.52

1.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

166

1.27

0.52

1.4

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

106

0.66

0.52

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

136

1168

0.91

0.52

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

760

6160

0.96

0.50

1.4

1.5

12.2

15.9

u/ml

0.31

152

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.63

0.49

1.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.63

0.49

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

140

1.28

0.49

2.1

2.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

127

900

1.10

0.47

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

260

0.81

0.47

1.7

1.2

mmol/l

0.43

250

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1028

8267

0.97

0.46

2.0

2.2

11.5

14.7

nmol/l

24.79

880

7283

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.34

0.46

1.3

1.2

0.1

0.2

nmol/l

0.57

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

163

1173

1.08

0.45

1.1

1.2

96.3

95.5

0.16

146

1096

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

639

4795

1.04

0.44

1.1

6.6

10.3

u/ml

0.20

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.33

0.43

1.3

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

377

3088

0.95

0.42

3.8

3.5

35.7

26.4

mg/l

4.56

247

2011

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.41

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.41

0.41

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

244

1.18

0.41

1.0

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.41

0.0

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

1.38

0.40

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

173

1.22

0.40

1.1

1.2

8.8

268802.0

nmol/l

1.08

141

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

271

0.83

0.40

2.0

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

321

0.85

0.39

1.0

1.1

—

(4133840)

337

0.86

0.38

1.4

1.2

—

(3045414) Leukocytes [Presence] in Urine

797

6025

1.03

0.38

2.0

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6427

49658

1.01

0.38

4.6

4.1

—

(44806071)

159

0.78

0.38

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

13401

104016

1.01

0.38

39.3

16.2

14.8

13.7

307.65

13222

101401

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.32

0.37

14.0

9.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

319

0.86

0.37

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

139

1.23

0.37

1.3

1.6

—

(3000285) Sodium [Moles/volume] in Blood

218

0.82

0.37

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

377

0.87

0.37

1.3

1.6

13.1

9.2

ug/l

2.47

377

(3005011) Chlamydia sp Ab [Titer] in Serum

158

0.79

0.36

1.6

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.46

0.36

2.7

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

141

1182

0.93

0.36

1.2

1.5

—

(4024509)

168

1399

0.94

0.36

1.6

—

(3044927) Protein electrophoresis panel - Urine

217

1598

1.06

0.35

1.2

—

(3045424) Erythrocytes [Presence] in Urine

304

2260

1.05

0.35

1.7

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

291

0.86

0.34

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

214

1.17

0.32

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

704

1.09

0.32

1.4

1.3

0.3

0.2

nmol/l

0.40

526

(3024869) Neuronal Ab [Presence] in Serum

229

1.16

0.32

1.1

—

(3012898) Urea [Moles/volume] in Urine

135

1.21

0.31

1.2

1.3

198.0

164.6

mmol/l

0.31

124

(3033923) Metanephrine [Moles/time] in 24 hour Urine

297

0.87

0.31

1.1

0.6

0.7

umol/24h

0.25

132

(3023323) Follitropin [Units/volume] in Serum or Plasma

282

2301

0.95

0.31

1.3

38.6

33.8

iu/l

1.19

232

1980

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

128

1.22

0.31

1.1

1.0

87.5

81.5

ug/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

321

0.87

0.30

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

218

1615

1.05

0.30

1.2

2.8

4.0

u/ml

2.11

107

730

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.73

0.29

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

117

976

0.93

0.28

1.8

2.0

7.7

7.0

mmol/l

1.22

659

(3020961) Endomysium IgA Ab [Titer] in Serum

643

5150

0.97

0.28

1.1

207.3

212.1

titre

0.02

122

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

519

3927

1.03

0.27

1.4

1.5

15.4

15.2

iu/ml

0.01

104

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

512

3874

1.03

0.27

2.5

2.3

132.5

112.4

ug/min

0.40

294

2241

(3030313) Adrenal Ab [Titer] in Serum

0.68

0.26

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6837

52967

1.01

0.26

4.6

3.8

2.8

2.3

ug/l

2.60

5910

47608

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

316

0.89

0.26

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

233

1741

1.04

0.25

1.4

1.3

92.1

60.6

mu/l

0.74

206

1545

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

139

1.18

0.25

1.0

1.2

—

(40761535) Cells panel - Urine sediment

1501

11883

0.98

0.24

3.6

3.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.71

0.24

1.0

1.2

—

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

12575

97714

1.01

0.24

3.9

4.2

17.9

12.5

mm/h

173.55

11477

89710

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.17

0.23

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

220

1647

1.04

0.23

1.2

4.0

3.8

u/ml

0.09

574

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.21

0.22

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.22

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.22

0.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

401

0.91

0.21

1.2

1.3

34.7

35.6

0.05

267

(4198724)

282

1.11

0.21

1.4

2.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3019174) dRVVT (LA screen)

105

0.82

0.21

1.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.0

—

135.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

237

1783

1.04

0.20

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

638

1.06

0.20

1.2

—

(4306422)

198

1601

0.96

0.18

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

129

1.15

0.18

2.4

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

372

0.92

0.18

1.5

1.2

0.3

g/l

0.17

301

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.16

0.18

1.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.11

0.17

1.1

1.3

1.4

1.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.74

0.17

1.2

1.0

0.8

1.3

u/ml

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.72

0.17

19.6

13.3

397.8

224.6

e6/l

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.75

0.15

1.0

1.1

—

34.8

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.75

0.15

1.0

1.1

—

26.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.75

0.15

4.7

3.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

232

0.91

0.15

1.1

1.0

0.7

0.9

u/ml

—

113

(3020191) Ethanol [Moles/volume] in Serum or Plasma

139

1043

1.04

0.15

1.2

1.4

0.9

1.4

promille

4.14

109

791

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

1.14

0.15

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

426

1.06

0.14

7.0

7.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

303

0.93

0.14

5.7

7.5

—

(3029075) Extractable nuclear Ab panel - Serum

343

0.93

0.14

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

190

0.90

0.14

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

201

1612

0.97

0.14

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1117

8804

0.99

0.13

1.2

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

294

0.93

0.13

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

165

0.90

0.13

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

301

0.93

0.12

1.1

1.3

1.0

36.0

mg/l

1.00

233

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.86

0.12

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.87

0.12

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

188

0.91

0.12

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

792

0.96

0.11

14.3

10.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

608

4798

0.99

0.10

1.5

1.6

240.0

283.2

titre

0.15

237

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

122

0.89

0.10

1.4

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

282

2159

1.02

0.10

2.2

1.8

302.7

290.6

mu/l

0.26

261

1977

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

457

0.96

0.10

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.11

0.10

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.08

0.09

1.0

1.2

—

mmol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

213

1627

1.02

0.09

1.2

1.3

337.5

269.6

pmol/l

0.50

161

1216

(4212803)

113

1.10

0.09

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

189

1.07

0.09

1.0

1.4

—

50.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.13

0.09

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.08

1.0

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.76

0.08

1.0

1.2

227.0

257.0

u/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.11

0.08

3.4

2.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

108

820

1.03

0.08

2.5

2.0

90.5

16.4

umol/l

1.52

(3017704) Immunofixation for Urine

743

1.03

0.08

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.82

0.07

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

328

1.05

0.07

1.0

1.2

302.3

299.8

pmol/l

0.01

226

(36660697) Celiac disease serology panel - Serum

1187

9314

0.99

0.07

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

175

1.07

0.07

2.2

2.3

40.9

41.4

umol/l

0.03

147

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

627

0.97

0.07

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

239

0.95

0.07

1.7

1.3

153.8

192.5

titre

—

(37021550) Renin [Units/volume] in Plasma --upright

275

1.05

0.07

1.0

1.3

168.0

61.0

mu/l

0.98

195

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.85

0.07

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.10

0.06

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.88

0.06

1.1

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.86

0.06

1.2

18.7

25.3

nmol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

646

1.03

0.06

1.1

—

(40768446) Kidney Pathology biopsy report

485

1.03

0.05

1.3

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

106

814

1.02

0.03

2.1

2.0

16.2

16.0

nmol/l

0.10

749

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

0.95

0.03

1.1

—

(3015183) Erythrocyte sedimentation rate

430

0.98

0.03

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

343

0.98

0.02

1.4

1.2

106.8

113.5

0.98

302

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

350

0.98

0.02

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

303

0.98

0.02

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

162

0.96

0.02

14.8

10.0

—

(3020650) Glucose [Presence] in Urine

295

0.98

0.01

1.3

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

199

1544

1.00

0.01

1.1

113.5

116.7

0.82

182

1383

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

419

0.99

0.01

1.6

1.4

14.7

16.2

pmol/l

1.31

352

(3025315) Body weight

122

0.96

0.01

5.1

4.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

528

0.99

0.01

2.4

2.2

55.4

56.9

umol/l

0.15

412

(3036525) Urea [Moles/time] in 24 hour Urine

1.06

0.00

3.3

2.8

—

(3034426) Prothrombin time (PT)

356

0.99

0.00

1.2

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

268

1.02

0.00

1.7

1.8

1.2

mmol/l

0.25

259

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

145

0.97

0.00

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

134

0.99

0.00

1.2

1.1

1.4

1.7

umol/24h

1.84

134

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

726

5664

1.00

0.00

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

371

2890

1.00

0.00

1.1

1.3

172.0

129.2

titre

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

658

1.00

0.00

1.2

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

406

1.00

0.00

5.5

6.0

60.8

70.5

1.22

341

(3035933) Granulocytes/100 leukocytes in Blood

190

0.98

0.00

1.2

1.6

—

(4146454)

236

1839

1.00

0.00

2.7

2.8

—

(4268621)

139

1082

1.00

0.00

2.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

260

0.99

0.00

1.0

1.2

—

290.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.04

0.00

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

373

1.00

0.00

7.3

7.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.93

0.00

1.2

1.0

0.1

0.0

mg/l

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.95

0.00

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.89

0.00

2.4

7.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.00

0.00

1.8

1.3

506.6

326.9

umol/24h

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.91

0.00

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.3

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

18.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.01

0.00

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.85

0.00

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.85

0.00

1.2

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.88

0.00

1.0

1.2

65.7

85.6

umol/l

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.0

—

12.2

—

(3017509) Phencyclidine [Presence] in Urine

0.89

0.00

1.5

1.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

1.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS_EXALLC – Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints